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Abstract 
The products of the five-membered PRS gene family in S. cerevisiae exist as three 
entities, Prs1/Prs3, Prs2/Prs5 and Prs4/Prs5, each capable of supporting cell 
viability. The signal generated from an integrated GFP-Prs1 construct is dependent 
on the presence of Prs3. Prs1 not only interacts with Prs3 but also with Slt2, the 
MAPK of the Cell Wall Integrity (CWI) pathway as shown by co-immunoprecipitation 
and confirming previous Y2H studies that the central region of Prs1, NHR1-1, is 
essential for the interaction with the CWI pathway. Point mutations in PRS1 
corresponding to missense mutations associated with human neuropathies or in the 
divalent cation- and/or PRPP-binding sites interfere with CWI signalling resulting in 
temperature and/or caffeine sensitivity. The synthetic lethality of a strain lacking 
PRS1 and PRS5 can only be rescued by versions of Prs1 containing NHR1-1, 
implying that impaired CWI contributes to this loss of viability. Prs5 is unusual in that 
it contains two NHRs, one, NHR5-2, contains three phosphorylation sites. Mutation of 
these amino acid residues impinges on the expression of the transcription factor, 
Rlm1, an endpoint of the CWI pathway and reduces the temperature-dependent 
transcription of FKS2, the gene encoding the stress-induced catalytic subunit of 1,3-
β-glucan synthase essential for maintaining CWI. This finding emphasizes the 
functionality of the three phosphorylation sites located in NHR5-2 of Prs5. The data 
presented support the hypothesis that the PRS gene family has, as a result of gene 
duplication and acquisition of NHRs, evolved to link primary metabolism with CWI.   
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1 Introduction  
PRPP synthetase (5-phosphoribosyl-1(α)-pyrophosphate synthetase (Prs; E.C 
2.7.6.1) catalyzes transfer of the terminal diphosphoryl group from ATP to the C1-
hydroxyl group of ribose-5-phosphate to generate phosphoribosyl pyrophosphate 
(PRPP) and AMP (Khorana, 1960, Miller et al., 1975, Becker, 2001) (Figure 1.1). It 
requires Mg2+ and inorganic phosphate (Pi) for activity and is also subject to 
feedback inhibition by ADP and GDP (Olszowy and Switzer, 1972, Garcia-Pavia et 
al., 2003, Tang et al., 2006).  
The product of Prs, PRPP, is a key metabolite that plays a central role in many 
biosynthetic pathways, such as the de novo and salvage biosyntheses of purine, 
pyrimidine and pyridine nucleotides, NAD+ and NADP+ (Becker, 2001) and for the 
production of the amino acids histidine and tryptophan (Hove-Jensen, 1989, Hilden 
et al., 1995). Prs is of biochemical importance as it links carbon and nitrogen 
metabolism in the cell by connecting ribose-5-phosphate from the pentose 
phosphate pathway (PPP) with the nucleotide synthesis pathway (Miller et al., 1975, 
Hove-Jensen et al., 1986, Tozzi et al., 2006, Kleineidam et al., 2009) and is therefore 
essential for life in all organisms with the  exception of parasites, such as 
Trypanosoma and Leishmania that solely depend on the host’s metabolism (Ullman 
and Carter, 1997). Prs enzymes have been identified in bacteria, fungi, plants and 
humans. For example, in Mycobacterium tuberculosis, the main cause of 
tuberculosis, there is only a single gene encoding PRS, Mt-prsA (Rv1017c), which 
has been shown to be essential for the maintenance of cell integrity because it 
provides the only source of PRPP for the cell wall biosynthetic precursor decaprenol-
1-monophosphoarabinose and is therefore a potential drug target (Lucarelli et al., 
2010, Alderwick et al., 2011). 
There are three classes of Prs, based on its requirement for phosphate, allosteric 
regulation and specificity for the diphosphoryl donor (Eriksen et al., 2000, Kadziola et 
al., 2005, Li et al., 2007). Most PRPP synthetases belong to class I, also named 
“classical”. Class I Prs enzymes are dependent on phosphate and Mg2+ ions for their 
activities and are regulated allosterically by ADP because of their exclusive use of 
either ATP or dATP as a diphosphoryl donor (Switzer, 1969, Kita et al., 1989, Li et 
al., 2007, Jiménez et al., 2008, Cherney et al., 2011). In Bacillus subtilis Prs, ADP is 
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a competitive inhibitor when it binds to the ATP-binding site and acts as an allosteric 
inhibitor when it competes with Pi at the allosteric site (Eriksen et al., 2000). It has 
been shown that the crystal structure of Bacillus subtilis forms a hexamer and is 
organised as a propeller with the N-terminal domain at the centre and the C-terminal 
domains at the outside. The catalytic site contains both ATP- and ribose-5-
phosphate-binding sites (Eriksen et al., 2000).  Structural determination of class I 
PRPP synthetase of B. subtilis (Eriksen et al., 2000), Bacillus pseudomallei (Cherney 
et al., 2011) and human PRPS (Li et al., 2007) showed 50% aa similarity in their 
monomeric sequences which aggregate to form a hexameric (α2)3 quaternary 
structure organized as a trimer of dimers. Their allosteric sites are in proximity to the 
active site at the junction of three subunits, of which two of the subunits are in the 
same dimer while the third subunit comes from an adjacent dimer (Cherney et al., 
2011).  
Class II PRPP synthetases are specific to plants and do not require phosphate ions 
for activity. They have the ability to utilize a wide range of diphosphoryl donors, such 
as ATP, dATP, CTP, GTP and UTP and are not allosterically inhibited by ADP. They 
have the least sequence similarity (<20%) when compared with class I and class III 
enzymes (Krath et al., 1999, Krath and Hove-Jensen, 2001, Jiménez et al., 2008, 
Cherney et al., 2011, Breda et al., 2012).  
Class III PRPP synthetases are a novel class of PRPP synthetases found in the 
Archaea Methanocaldococcus jannaschii. Its activation depends on phosphate ions 
and Mg2+-ions. It uses ATP as the diphosphoryl donor and is not allosterically 
inhibited by ADP, but is tightly regulated by competitive inhibition (Kadziola et al., 
2005). A sequence similarity of ≈ 23% with class I PRPP synthetase and 18% and 
12% with class II PRPP synthetase from Spinacia oleracea isozyme 3 and 4, 
respectively, has been reported (Cherney et al., 2011).  
Genes encoding Prs have been identified in a variety of organisms. Prokaryotes 
contain only one PRS gene while eukaryotes have more than one PRS gene. For 
example, Arabidopsis thaliana and S. oleracea possess five and four PRS genes, 
respectively (Krath et al., 1999). Five PRS genes have been identified in S. 
cerevisiae (Hernando et al., 1999), two in Rattus norvegicus (Taira et al., 1987) and 
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three in humans (Iizasa et al., 1989, Taira et al., 1989, Taira et al., 1990, Sonoda et 
al., 1991, Becker and Ahmed, 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ribose-5-phosphate from the pentose phosphate pathway reacts with ATP to yield phosphoribosyl 
pyrophosphate (PRPP). This reaction is catalysed by the enzyme 5-phosphoribosyl-1(α)-
pyrophosphate synthetase (Prs). Its product is utilized in the de novo synthesis and salvage pathway 
of nucleotides (purine, pyridine and pyrimidine) and synthesis of histidine and tryptophan in bacteria 
and yeast (taken from (Jensen et al., 2008)). 
 
1.1 Human PRS genes and associated hereditary disorders 
In humans there are three separate isoforms of PRPP synthetase, hPRPS1 (MIM 
311850), hPRPS2 (MIM 311860) and hPRPS1L1 (MIM 611566) which display high 
sequence homology (between hPRPS1 and hPRPS2 (95%); hPRPS1 and 
hPRPS1L1 (94.3%); hPRPS2 and hPRPS1L1 (91.2%)) (Li et al., 2007). The genes 
hPRPS1 and hPRPS2 are located on the X-chromosome and map to the long and 
short arms of the X-chromosome, respectively; they are expressed in all tissues 
while hPRPS1L1 maps to chromosome 7 and appears to be testis-specific (Becker, 
2001, Li et al., 2007). Studies on hPRPS1 and hPRPS2 showed that their cDNAs 
Prs 
Figure 1.1: The biosynthesis and metabolic fates of phosphoribosyl pyrophosphate 
(PRPP) 
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hybridize with transcripts of 2.3 kb and 2.7 kb, respectively. Their tissue-specific 
expression indicates that hPRPS1 may be constitutively expressed while hPRPS2 
may be activated by mitogenic agents (Becker, 2001). 
In addition, Prs-associated proteins (PAPs) have been discovered in humans, thus 
increasing the complexity of human PRPP biosynthesis and its expression (Kita et 
al., 1989, Tatibana et al., 1995, Katashima et al., 1998). Human PAPs have a high 
degree of aa sequence similarity to the hPRPS proteins but contain mutations in 
residues conserved in Prs proteins of other organisms implying that their catalytic 
properties are compromised (Kleineidam et al., 2009). In rat liver, there is evidence 
that PAP39 interacts with PRPP synthetase and inhibits catalytic activity through 
reversible association (Tatibana et al., 1995). 
In humans mutations in PRPS genes are associated with several syndromes, such 
as PRS1 superactivity, Arts syndrome, Charcot-Marie-Tooth disease (CMTX5) and 
X-linked nonsyndromic sensorineural deafness (DFN2). Human PRPS1 superactivity 
is an X-linked disorder resulting from gain of function which causes superactivity of 
the enzyme thus leading to overproduction of uric acid which causes gout and leads 
to urolithiasis in men (Nyhan et al., 1969, Sperling et al., 1972, Becker et al., 1986, 
Becker et al., 1988, Becker et al., 1989, Roessler et al., 1993, Becker et al., 1996, 
Ahmed et al., 1999, Synofzik et al., 2014). It is also associated with the occurrence 
of infectious diseases in the upper respiratory tracts which can be fatal. On the other 
hand, reduced Prs activity is characteristic of certain neuropathies. Arts syndrome is 
characterized by mental retardation, delayed motor development, ataxia, hearing 
impairment and optic atrophy and is associated with two missense mutations in 
hPRPS1, L152P and Q133P (Arts et al., 1993). CMTX5, a neuropathic disorder 
characterized by loss of muscle tissue and touch sensation, has been linked to a 
missense mutation (M115T) in hPRPS1. CMTX5 affects approximately 1 in 2,500 
people, and is one of the most common inherited disorders (Synofzik et al., 2014). 
DFN2 is associated with hearing impairment (Liu et al., 2010, de Brouwer et al., 
2010). Another neuropathy, Rosenberg-Chutorian syndrome, is associated with the 
mutation E43D in hPRPS1 (Kim et al., 2007). Interestingly, there is high sequence 
similarity between hPRPS1 and S. cerevisiae Prs1, particularly between the region 
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of hPRPS1 harbouring the mutations associated with neuropathies mentioned above 
and the sequence of the N-terminal region of Prs1 (http://www.yeastgenome.org). 
 
1.2  Prs-encoding genes in Saccharomyces cerevisiae 
The Saccharomyces cerevisiae genome contains a family of five genes (PRS1-
PRS5) located on different chromosomes, each containing characteristic motifs of 
Prs polypeptides capable of encoding PRPP synthetase: a divalent cation-binding 
domain located at the N-terminus and a PRPP-binding site close to the C-terminus 
(Hove-Jensen et al., 1986, Carter et al., 1994, Hernando et al., 1999).  
PRS1 is located on chromosome XI, PRS2 on chromosome V, PRS3 on 
chromosome VIII, PRS4 on chromosome II and PRS5 on chromosome XV (Carter et 
al., 1997). PRS2, PRS3 and PRS4 each have a length of 318-320 aa with a 
corresponding molecular weight of 34.7 KDa, 35.1 KDa and 39 KDa, respectively, 
whereas PRS1 and PRS5 are longer and consist of 427 and 495 aa, respectively 
and molecular weights of 47 KDa for Prs1 and 53.5 KDa for Prs5 (Hernando et al., 
1998, Schneiter et al., 2000, Kleineidam et al., 2009). The reason for the longer 
lengths of Prs1 and Prs5 is that they contain non-homologous regions (NHRs) that 
increase their lengths by at least one-third. These NHRs are in-frame insertions 
which are not introns (Carter et al., 1997, Hernando et al., 1998, Hernando et al., 
1999, Vavassori et al., 2005b). Specifically, the NHR1-1 of Prs1 is an insertion of 
105 aa residues bearing no homology to Prs2, Prs3, Prs4 or Prs5 and is located 
between the divalent cation-binding and PRPP-binding sites. Prs5 possesses two 
NHRs; NHR5-1 and NHR5-2. NHR5-1 consists of 70 aa and is located N-terminal to 
the divalent cation-binding site, NHR5-2 consists of 116 aa and is located at a similar 
position to NHR1-1 of Prs1, i. e. it separates the divalent cation- and PRPP-binding 
sites. Furthermore, as a result of phosphoproteome analysis Prs5 was found to be 
one of the 11 triply phosphorylated proteins in yeast (Ficarro et al., 2002). The three 
neighbouring phosphorylatable sites are located in NHR5-2 (Figure 1.2). 
Interestingly, it was postulated that Prs5 may be a protein kinase based on protein 
microarray assay (Fasolo et al., 2011). The authors have classified Prs5 as a protein 
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kinase possibly because of it being theoretically capable of donating a phosphate 
group to ribose-5-phosphate to yield PRPP. 
 
 
Figure 1.2: The structure of the five PRPP synthetase polypeptides 
The figure shows the relative lengths of the Prs1- Prs5 polypeptides. Vertical green lines represent 
the divalent cation-binding sites (DCBS) and blue vertical lines show the PRPP-binding sites. The 
yellow rectangle indicates the location of NHR1-1 in Prs1.The magenta rectangle corresponds to the 
position of NHR5-1 while the red rectangle represents NHR5-2. The phosphosites (Ficarro et al., 
2002) are indicated in green and followed by a “p” (phosphate group) (reproduced by kind permission 
of M Schweizer). 
 
 
1.3 Cell wall integrity signalling pathway in S. cerevisiae 
The cell wall of S. cerevisiae has four distinct functions. Firstly, it stabilizes the 
internal osmotic conditions of cytoplasm and limits the water influx that would perturb 
and cause swelling or rupture of the plasma membrane (Klis et al., 2006, Levin, 
2011). Secondly, it serves as protection against mechanical damage, physical stress 
and maintains osmotic homeostasis of the cell through prevention of sheer and 
compression forces (Kim et al., 2008, Levin, 2011). Thirdly, the cell wall maintains 
cell shape which is essential for vegetative growth, cell division and during 
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pheromone-induced morphogenesis and pseudohyphal development (Klis et al., 
2006).  Fourthly, the cell wall functions as a scaffold for surface proteins; with the 
stress-bearing polysaccharides supporting the matrix of cell wall glycoproteins. 
These glycoproteins, especially those with N-linked carbohydrate side-chains, limit 
the permeability of the cell wall for macromolecules, and protect the glycan layer 
from the attack by cell wall-degrading enzymes or foreign proteins (Klis et al., 2006, 
Levin, 2011). 
 
 
The nomenclature of proteins involved in MAPK signalling is indicated to the left of the components of 
the CWI pathway. Signals are initiated at the cell surface receptors traversing the plasma membrane 
(PM). Two transcription factors, Rlm1 and Swi4/Swi6 are activated through a cascade of MAPK from 
Rho1 which is activated by GEFs Rom1/2 following receptor stimulation. In addition to Pkc1 Rho1 
activates four other effectors: β-1,3-glucan synthase (GS), the Bni1 formin protein, the exocyst 
component Sec3 and the Skn7 transcription factor which may contribute to the CWI transcriptional 
programme. PiP2 = phosphatidylinositol-4,5-bisphosphate. Mpk1 and Slt2 are synonyms (taken from 
(Levin, 2011)).  
Figure 1.3: Scheme of the CWI signalling pathway 
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S. cerevisiae invests a considerable amount of energy in the construction of its cell 
wall which comprises 10–30% of the cell’s dry weight and 80-90% of the 
polysaccharide content (Aguilar-Uscanga and François, 2003, Klis et al., 2006). 
Specifically, the cell wall of S. cerevisiae  consists of chitin, β-1,3-glucan, β-1,6-
glucan, and glycoproteins which have the ability to form covalent complexes (Molina 
et al., 2000, Aguilar-Uscanga and François, 2003, Free, 2013). Electron microscopy 
has shown that the inner layer of the cell wall is comprised mainly of 1,3-β-glucan 
polymers and chitin. This layer is responsible for the elastic property and mechanical 
strength of the cell wall owing to the helical nature of β-1,3-glucan chains (Levin, 
2011). Although chitin makes up only 1-2% of the cell dry weight, it has been found 
to be essential for S. cerevisiae viability and increases in content under cell wall 
stress (Klis et al., 2006) and this has been demonstrated in PRS deletant strains 
(Wang et al., 2004). 
A linear series of protein kinases, known as Mitogen-Activated Protein Kinases 
(MAPK) relay signals by means of sequential phosphorylation (Manning et al., 2002, 
Zhang et al., 2003, Edmunds and Mahadevan, 2004, Qi and Elion, 2005, Akella et 
al., 2008) (http://kinase.com/scerevisiae/). The MAPK signalling pathways have been 
widely studied in S. cerevisiae and each comprises a highly conserved cascade of 
three protein kinases: MAP3K, MAP2k and MAPK. One of the five yeast MAPK 
pathways (Furukawa and Hohmann, 2013) is the well-studied cell wall integrity (CWI) 
pathway which is induced in response to cell wall stressors, such as increased 
temperature, hypo-osmotic shock, exposure to mating pheromone and agents that 
interfere with the cell wall, e.g. Congo red, caffeine, the chitin antagonist Calcofluor 
White or zymolyase (Stark, 2004, Levin, 2005, Kuranda et al., 2006, Chen and 
Thorner, 2007, Fuchs and Mylonakis, 2009, Rodicio and Heinisch, 2010, Heinisch 
and Dufrêne, 2010). The CWI signalling pathway is comprised of a family of five 
receptor proteins located at the plasma membrane: Wsc1-3, Mid2 and Mtl1 which 
are coupled to the small G-protein, Rho1 (Figure 1.3). It has been shown by single-
molecule atomic force microscopy that Wsc1 is a sensor which in response to 
external stimuli reacts like a “nanospring” (Heinisch and Dufrêne, 2010). Rho1 
encodes a GTP-binding protein and is involved in the maintenance of cell polarity 
and reorganisation of the actin cytoskeleton (Madden and Snyder, 1998) as well as 
activating a set of effectors which play essential roles in signalling events including 
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the CWI pathway. Rho1 binds and activates Pkc1, the yeast homologue of 
mammalian protein kinase C, which in turn controls the MAPK cascade (Nonaka et 
al., 1995, Heinisch, 2005). Yeast Pkc1 is much larger than the mammalian PKCs 
because it possesses a regulatory domain with all the subdomains that are 
distributed to the different isoforms of mammalian PKCs. Pkc1 is activated by the 
Phk1 and Phk2 kinases (Inagaki et al., 1999, Friant et al., 2001, Levin, 2005) and by 
TOR via nutrient depletion which results in dissociation of the Sit4/Tap42  complex 
and activation of the CWI pathway (Torres et al., 2002, Loewith and Hall, 2011, Yan 
et al., 2012). The CWI MAPK cascade consists of a MAP3K/MEKK (Bck1), a 
redundant pair of MAP2KK/MEK (Mkk1/2), and a MAPK (Mpk1/Slt2) (Levin et al., 
1994, Kim et al., 2008, Kim and Levin, 2010, Lee et al., 2011). It has been observed 
that loss of Pkc1 function or any component of the MAPK cascade under the control 
of Rho1 results in a cell lysis defect (Levin, 2005, Kim et al., 2008). A further role for 
Rho1 is that it is an integral regulatory subunit of the 1,3-β-glucan synthase (GS) 
complex encoded by FKS1 and FKS2. This enzyme complex synthesizes 1,3-β-
glucan from UDP glucose thereby contributing to cell wall construction (Douglas et 
al., 1994, Mazur et al., 1995, Ram et al., 1995). In yeast the three nucleotide 
exchange factors (GEFs) Rom1, Rom2 and Tus1 activate Rho1 (Krause et al., 
2012). Rom1 and Rom2 are homologous proteins whereas TUS1 is more distantly 
related and as a result of CDK phosphorylation ensures that Rho1 is recruited to the 
site of bud emergence (Levin, 2005, Kono et al., 2008, Yoshida et al., 2009). Rom2 
is the major GEF responsible for transmitting signals from the cell surface to Rho1 
for activation of the CWI pathway (Guo et al., 2009). Rom2 interacts with the plasma 
membrane via its pleckstrin homology domain which binds phosphatidylinositol-4,5-
bisphosphate (PIP2) and it also interacts with the cell surface receptor proteins, e. g. 
Wsc1 and Mid2 (Philip and Levin, 2001). During normal cell growth, Rom2 and Rho1 
are co-localized to the bud neck (Manning et al., 1997) and are redistributed to the 
cell periphery in response to environmental stress where together with β-1,3-GS they 
are responsible for remodelling the cell wall (Guo et al., 2009).  
Targets affected by the activation of Rho1 include Pkc1, β-1,3-GS, Bni1, Bnr1, Skn7 
and Sec3. Bni1 and Bnr1 are formin proteins involved in actin filament assembly 
(Evangelista et al., 1997, Wen and Rubenstein, 2009). Rho1 oscillates between the 
active GTP-bound form and the inactive GDP-bound form which is regulated by 
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Rom2 resulting in the activation of the protein. The GTP-activating proteins (GAPs) 
are: Bem2, Sac7, Bag7 and Lrg1 (Mart  n et al., 2000, Schmidt et al., 2002). 
Following activation by Rho1 Pkc1 then switches on the MAPK cascade which 
amplifies the CWI signal. Specifically, Pkc1 phosphorylates Bck1 at several sites in a 
hinge region between its putative regulatory and catalytic domains (Levin et al., 
1994). Bck1 then phosphorylates and activates Mkk1/Mkk2 based on Y2H 
interactions. Mkk1/Mkk2 then phosphorylates Mpk1/Slt2, a functional homologue of 
human ERK5, (Piper et al., 2006, Truman et al., 2006, Kim et al., 2008), on 
neighbouring threonyl and tyrosyl residues in a T-X-Y motif within the activation loop 
which is conserved in MAPKs and is analogous to Thr202/Tyr204 of mammalian 
p44/p42 MAPK (Erk) and can be detected by commercially available antibodies 
(Mart  n et al., 2000, de Nobel et al., 2000b). Interestingly, there is a paralogue of 
Mpk1/Slt2, Mlp1 (Mpk1-like protein). The two paralogues have 53% aa sequence 
identity but Mlp1 is not dually phosphorylated by Mkk1/Mkk2 since its T-X-Y motif is 
mutated to K-X-Y possibly allowing Mlp1 to be phosphorylated on Tyr192 (Kim et al., 
2008). 
The CWI pathway terminates in one of three targets: Rlm1, SBF and Sir3 (Jung and 
Levin, 1999, Jung et al., 2002, Ray et al., 2003, Garcia et al., 2004, Kim et al., 2008, 
Mascaraque et al., 2013). The transcription factor, Rlm1, a regulator of a wide array 
of cell wall biosynthetic genes, is phosphorylated on residues S427 and T439 by 
Mpk1/Slt2 (Jung et al., 2002, Heinisch and Dufrêne, 2010, Kim and Levin, 2011). 
Mlp1 is also a target of Rlm1 (Kim et al., 2008). Under non-stress conditions 
Mpk1/Slt2 is found mainly in the nucleus, however, in response to temperature 
stress some of the protein is rapidly moved to the cytoplasm (Kamada et al., 1995, 
Hahn and Thiele, 2002). Furthermore, a small proportion of Mpk1/Slt2 is found at 
sites of polarized cell growth since it shuttles constitutively between this location and 
the nucleus (Delley and Hall, 1999, van Drogen and Peter, 2002, Denis and Cyert, 
2005, Li et al., 2013). In addition to regulation of gene expression Mpk1/Slt2 is also 
involved in the polarization of the actin cytoskeleton (Guo et al., 2009) and may be 
regarded as part of the checkpoint mechanism for morphogenesis (Harrison et al., 
2001). Furthermore, Mpk1/Slt2 has been implicated in the cellular response to 
oxidative stress by controlling cyclin C degradation (Krasley et al., 2006). Mpk1/Slt2 
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interacts with Hog1, a functional homologue of mammalian p38 MAPK, in adaptation 
to zymolyase-mediated cell wall stress (Chen and Thorner, 2007).  
The second target of Mpk1/Slt2 is SBF, a heterodimeric G1-regulator composed of 
Swi4 and Swi6 which links CWI signalling to cell cycle metabolism (Madden et al., 
1997, Baetz et al., 2001, Queralt and Igual, 2005, Heinisch and Dufrêne, 2010). The 
biological evidence that SBF participates in CWI signalling is: (i) the cell lysis defect 
of an mpk1Δ mutant is suppressed by overexpression of Swi4, (ii) Swi4 and Swi6 
mutants are hypersensitive to Calcofluor White, (iii) Mpk1/Slt2 associates with the 
dimeric SBF in vivo, (iv) Swi6 is phosphorylated in vivo and in vitro by Mpk1/Slt2 in 
response to cell wall stress (Kim et al., 2008).  
The transcriptional silencer Sir3 is another target of Mpk1/Slt2, thus implicating the 
CWI pathway in silencing and shortened lifespan (Ray et al., 2003). Mpk1/Slt2 is 
also regulated by four protein phosphatases – Msg5, Ptp2, Ptp3 and Sdp1 (Kamada 
et al., 1995, Keyse, 2000, Flandez et al., 2004, Mart  n et al., 2005, Marín et al., 
2009). Furthermore, Mpk1/Slt2 is responsible for feedback regulation of the CWI 
pathway since Msg5, Rom2, and Mkk1/Mkk2 are among its targets (Jiménez-
Sánchez  et al., 2007, Guo et al., 2009, Molina et al., 2010). 
Rlm1 and SBF cooperate in regulating the expression of Fks2, the 1,3-β-GS subunit 
which is activated under stress conditions (Levin, 2011, Kim and Levin, 2011). In 
addition, the pseudokinase paralogue of Mpk1, Mlp1, also interacts with the FKS2 
promoter as does the kinase-inactive form of Mpk1/Slt2 (mpk1/slt2-K54R) implying 
that FKS2 transcription is not reliant on the kinase activity of Mpk1/Slt2 (Kim et al., 
2008, Kim and Levin, 2010, Kim and Levin, 2011). In fact, the CWI signalling 
responsible for FKS2 transcription is the result of a combination of the catalytic and 
non-catalytic functions of Mpk1 (Kim and Levin, 2011). In order for FKS2 
transcription to take place it requires the recruitment of Mpk1/Slt2, Swi4 and Swi6 to 
its promoter. Following recruitment of the Paf1C complex – one of the two RNA 
polymerase II complexes in yeast, which is responsible for the expression of less 
than 5% of yeast genes, including some whose products are involved in cell wall 
biosynthesis (Jaehning, 2010) – to the FKS2 promoter Mpk1/Slt2 migrates from the 
Swi4/Swi6 complex to interact with Paf1C, thus promoting the transcription 
elongation of Fks2. It is known that Mlp1 is induced by Rlm1 activation thereby 
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providing an interesting feedback activation loop which enhances the non-catalytic 
function of Mlp1 expression (Kim and Levin, 2011).   
 
1.4 PPRP synthetase gene deletions in S. cerevisiae  
Genetic evidence shows that the PRS gene products of S. cerevisiae are organized 
into two functional interacting complexes, one of which is a heterodimer (Prs1/Prs3) 
and the other a heterotrimer (Prs2/Prs4/Prs5). Within these two interacting 
complexes three minimal essential functional units have been identified of which at 
least one combination must be present to guarantee viability (Hernando et al., 1999). 
Y2H analysis data have shown the existence of two interacting functional complexes 
in the cell which may have compensatory function since in the absence of one entity 
or a  component thereof, the cell can still survive (Wang et al., 2004).   
 
Figure 1.4: Functional entities and phenotypic minimal functional units of S. 
cervisiae Prs 
(a) Functional entities: Prs1/Prs3 and Prs2/Prs4/Prs5. (b) Minimal functional units: Prs1/Prs3, 
Prs2/Prs5 and Prs4/Prs5. The non-homologous regions (NHRs) of Prs1 and Prs5 are indicated by 
white boxes. 
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It has been observed through systematic phenotypic analysis that: (i) synthetic 
lethality occurs when PRS1 or PRS3 is deleted from a strain lacking PRS5 and also 
loss of PRS1 or PRS3 in combination with simultaneous deletion of PRS2 and PRS4 
results in non-viability; (ii) deletion of PRS1 and PRS3 in combination with a lack of 
PRS2 or PRS4 results in reduction of growth rate, nucleotide content and enzymatic 
activity; (iii) combinatorial deletion of PRS2, PRS4 and PRS5 causes an 80% 
reduction in enzymatic activity but has no effect on growth rate and nucleotide 
content (Carter et al., 1994, Hernando et al., 1998, Hernando et al., 1999, Wang et 
al., 2004, Vavassori et al., 2005a). 
There are three viable triple deletant combinations: prs2Δprs4Δprs5Δ; prs1Δprs3Δ 
prs4Δ and prs1Δprs2Δprs3Δ; each capable of synthesizing PRPP, thus defining the 
three minimal functional subunits, Prs1/Prs3, Prs2/Prs5 and Prs4/Prs5 (Hernando et 
al., 1998, Hernando et al., 1999, Wang et al., 2004).  
Deletion of any single PRS gene is not a lethal event, a further indication that their 
products are to some degree compensatory. However, studies have shown that each 
PRS gene makes a contribution to cellular metabolism and physiology of S. 
cerevisiae. Loss of any of the Prs polypeptides has a severe effect on the expression 
of Rlm1, an output of the CWI pathway under normal growth conditions; e. g. 
deletion of PRS5 reduced Rlm1 expression by 30% and lack of PRS2 or PRS4 alone 
or in combination with PRS5 reduced Rlm1 expression by 80% whereas in prs1∆ 
and prs3∆ strains Rlm1 activation is reduced by over 90% and in prs2∆ and prs4∆ 
strains it is reduced to 20%  (Wang et al., 2004, Vavassori et al., 2005b, Wang, 
2005). Strains carrying single deletions of PRS1 or PRS3 have doubling times of 3 
and 2.5 hr, respectively, indicating a slow growth phenotype when compared to the 
1.6 hr doubling time of the WT. The double deletant strains lacking PRS1 and PRS3 
or lacking PRS1 or PRS3 in combination with any other PRS deletant have doubling 
times of 3.5-4.0 hr whereas triple deletant strains prs1∆prs2∆prs3∆ and 
prs1∆prs3∆prs4∆ have a doubling time of approximately 5 hr (Hernando et al., 
1999). Electron microscopic analysis showed that prs2∆prs4∆prs5∆ and 
prs1∆prs3∆prs4∆ have a high incidence of plasma membrane invaginations while 
cytoplasmic vesicle accumulation was observed in prs1∆prs3∆prs4∆ strains 
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indicating defects in growth polarization as well as impaired fusion of the non-
targeted vesicles to the cell membrane (Schneiter et al., 2000).  
It is well known that the mating pheromone, α-factor, induces morphological changes 
in the cell wall of yeast thus activating the CWI pathway (Buehrer and Errede, 1997). 
Treatment of prs∆ strains with 1 µM α-factor for 6 hr revealed that in comparison to 
the WT, strains lacking PRS1 or PRS3 displayed 46% and 73% reduction in viability, 
respectively, while simultaneous deletion of PRS1 and PRS3 had an additive effect. 
On the other hand the α-factor sensitivity of prs1∆prs3∆ was overcome by the 
additional deletion of either PRS2 or PRS4 (Wang, 2005). Measuring Rlm1 
expression following exposure to 2 µM α-factor of the WT or prs5∆ caused a 20% 
and 50% reduction, respectively, in Rlm1 activation whereas deletion of PRS2 
increases Rlm1 activation five-fold while deletion of PRS4 caused a two-fold Rlm1 
activation (Wang et al., 2004).  
The expression of the FKS2 gene, which encodes an alternative catalytic subunit of 
the 1,3-β-GS, in strains carrying deletions of PRS genes showed that Fks2 
expression is reduced at 30°C and does not increase at elevated temperature when 
PRS3 is absent. Lack of PRS1 reduces the level of Fks2 expression at 30°C, but still 
allows an increase, albeit reduced in comparison to the WT, in Fks2 expression at 
37°C. On the contrary, strains deleted for PRS2 or PRS4 were still able to activate 
Fks2 expression to a similar level to that of the WT. However, in prs5∆ and 
prs1∆prs3∆ strains Fks2 expression was reduced at  30°C and reduced further at 
37°C (Wang et al., 2004, Vavassori, 2005). 
When the chitin content of PRS deletant strains was measured in the presence or 
absence of CFW, the strains deleted for PRS2, PRS4 or PRS5, individually or in 
combination, responded in the same way as the WT, On the other hand, deletion of 
PRS1 or PRS3 caused a three-fold increase in chitin content and impairs the ability 
of the cell to increase its chitin content upon exposure to CFW. The prs1∆, prs3∆ 
and prs1∆prs3∆prs4∆ strains showed resistance to CFW, whereas the double 
deletant prs1∆prs3∆ and the triple deletant prs1∆prs2∆prs3∆ were sensitive to CFW 
(Wang et al., 2004, Wang, 2005). 
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Caffeine sensitivity is a characteristic phenotype of yeast strains with a compromised 
CWI pathway (Cid et al., 1995, Hampsey, 1997, Kuranda et al., 2006) although it is 
an atypical activator thereof since it causes additional phosphorylation of Mpk1/Slt2 
via the DNA damage checkpoint pathway (Truman et al., 2009). Caffeine sensitivity 
of strains carrying PRS gene deletions has also been observed: (i) the WT strain is 
capable of growing at 6.5 mM caffeine as is a prs2∆ strain; (ii) deletion of either 
PRS1 or PRS3 results in inhibition of growth by 3.5 mM caffeine; (iii) prs4∆ and 
prs5∆ strains are inhibited by 6.0 mM and 5 mM caffeine, respectively; (iv) the 
double deletant strain prs1∆prs3∆ fails to grow on 2 mM caffeine but the triple 
deletant strain prs1∆prs3∆prs4∆ is less sensitive to caffeine than prs1∆prs4∆ and 
prs1∆prs2∆ double deletants (Schneiter et al., 2000, Wang et al., 2004).  
Furthermore, caffeine-associated release of alkaline phosphatase is restored by 
addition of 1 M sorbitol, an osmotic stabiliser, to the media (Schneiter et al., 2000), 
strongly indicating that the maintenance of CWI is compromised in these strains. 
Differential interference contrast (DIC) imaging of a GFP-PRS1 prs3∆ strain showed 
that this strain had highly vacuolated large spherical cells, a further indication that 
the CWI system is compromised (Schneiter et al., 2000).  
In an approach to see whether or not hPRPS1 mutations associated with human 
neuropathies exert an influence on CWI in yeast the corresponding mutations have 
been created in PRS1 at the positions L115T and Q133P which correspond to 
CMTX5 and Arts syndrome, respectively (Monnier, 2010, Wilkiewicz, 2010, 
Gallacher, 2014). Furthermore, in vitro-generated mutations in the divalent cation-
binding site (H130A), the PRPP-binding site (D326A) and the double mutation 
H130A/D326A have been created (Figure 3.6). In addition, in vitro-generated 
mutations of PRS5 at the postulated phosphorylatable sites were also created 
(Gallacher, 2014). These mutations have been investigated for their impact on yeast 
physiology since an understanding of the effect of altering PRPP-synthesizing 
capacity and its link to CWI signalling may give new insight into MAPK activation and 
cell wall remodelling events which can be useful for future therapeutic purposes. 
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1.5 Interaction of PRS genes with other genes 
 Protein-protein interactions are essential for virtually all biological processes. A 
comprehensive understanding of how Prs polypeptides interact with other 
polypeptides, the function(s) of the interacting polypeptides and how Prs 
polypeptides are regulated is indispensable for uncovering all the cellular functions of 
yeast Prs. System-wide assays of Prs interactions with other polypeptides using 
high-throughput Y2H (Uetz et al., 2000, Ito et al., 2001), Principal Component 
Analysis (PCA) (Tarassov et al., 2008), mass spectrometry  (tandem affinity capture-
MS) analyses (Ho et al., 2002, Gavin et al., 2006) and reconstituted complex/protein 
microarrays (a powerful tool to study protein functions and interactions) (Fasolo et 
al., 2011), revealed that Prs polypeptides interact with a myriad of other proteins 
(Appendix,  Table 2.1). Certain Prs polypeptide-interacting partners identified in high-
throughput analysis have been confirmed and extended by Y2H analysis in various 
lab-based projects (Vavassori, 2005, Wang, 2005, Kleineidam et al., 2009). Most of 
the identified polypeptides are protein kinases; others are associated with protein 
synthesis, and CWI signalling components. It has been shown that Prs1 physical 
interacts with proteins, such as Chk1, Elm1, Esa1, Hrr25, Kcc4, Npr1, Swe1, Ptk2, 
Pho85, Rpn4 and Tpk1, Ygk3. Chk1 is a DNA damage check-point effector, Elm1, a 
regulator of cellular morphogenesis and cytokinesis, Hrr25 regulates vesicular 
trafficking, and DNA repair, Ygk3 is involved in the control of Msn2-dependent 
transcription and Npr1 stabilizes plasma membrane aa transporters (Fasolo et al., 
2011). It has been reported by (Lin et al., 2009) that the Prs1 interacts with Esa1, a 
protein required for cell cycle progression and regulation of cellular 
acetylation balance.  
Prs2 has been found to interact physically with Nuf2, a protein involved in 
chromosome segregation, and spindle checkpoint activity (Uetz et al., 2000). This 
interaction has been confirmed and extended by Y2H. It would appear that an intact 
Prs2/Prs4/Prs5 complex is required for the interaction (Wang, 2005). This is an 
interesting observation in light of the fact that Pkc1 localizes to the mitotic spindle via 
its N-terminal C2-like domain (Denis and Cyert, 2005). 
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Reports on high-throughput analysis showed that Prs3 also interacts with a number 
of proteins (for details see Table 2.1). It is worthy of mention that overexpression of 
Prs3 completely rescued the caffeine sensitivity of a mutant allele of MPK1 
(mpk1siw9)   (Binley et al., 1999), thus supporting the hypothesis that Prs 
polypeptides interact with the CWI pathway.  
High-throughput analysis also shows that Prs4 and Prs5 physically interact with a 
variety of proteins including Ktr5 which is involved in protein glycosylation 
(Szappanos et al., 2011). The interaction of Prs5 and Bas1 is interesting since the 
latter induces expression of genes involved in purine and histidine biosynthesis 
(Fiedler et al., 2009).  
The association of Prs polypeptides uncovered by high-throughput analysis using 
protein microarray screens shows that Mkk1 which is an element of the CWI 
pathway physically interacts with Prs1 and Prs4 and is postulated to phosphorylate 
the former  (SGD PhosphoPep database) (Fasolo et al., 2011). Interestingly, Y2H 
analysis provided evidence that Mpk1/Slt2 also interacts with Prs1-Prs4 (Wang et al., 
2004). Ubp3, a protein that responds to osmostress (Ossareh-Nazari et al., 2010) 
was found by means of tandem affinity capture-MS to interact physically with Prs1, 
Prs3 and Prs5. Another stress responsive protein, Ubi4, interacts with Prs1-Prs5 
(Duttler et al., 2013, Swaney et al., 2013, Kolawa et al., 2013). Gnd1 a protein 
required for adaptation to oxidative stress (Szappanos et al., 2011) was identified by 
high through-put analysis to interact genetically with Prs2, Prs4 and Prs5. 
Sro9, a protein involved in haem regulation and in the organization of actin filaments 
(Schenk et al., 2012) interacts with Prs2, Prs3 and Prs5. Rim11, a serine/threonine 
protein kinase and a homologue of mammalian glycogen synthase kinase 3 (Gsk3) 
was shown to interact with Prs2,  Prs3 and  Prs5 as shown by Y2H (Kleineidam et 
al., 2009) confirming affinity capture-MS findings (Ho et al., 2002). A list of the Prs-
interacting proteins is provided in Appendix, Table 5.13. 
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1.6 Aim of study 
The main objectives of this study are to gain a better understanding of the S. 
cerevisiae PRPP synthetase and its contribution to cell physiology by exploitation of 
the large collection of yeast strains mutated/deleted for one or more of the PRS 
genes and Prs plasmids available in the laboratory carrying either specific yeast PRS 
mutations or mutations associated with human neuropathies linked to altered human 
PRPS activity. These phenocopies emphasise the potential role of yeast as a model 
organism for human disease/biology. This was achieved by: 
(i) Western blotting with GFP-tagged Prs1 in various PRS deletant strains to 
obtain biochemical evidence for the genetically defined Prs1/Prs3 
complex,  
(ii) expressing a His-tagged Prs5 construct in prs5∆ and prs2∆prs4∆prs5∆ 
strains followed by investigation of the Prs5-enriched extracts by MS/MS 
analysis to identify interacting proteins.   
(iii) co-immunoprecipitation to provide supporting physical evidence for the 
Y2H interaction of Prs1 with the cell wall integrity (CWI) pathway. The 
approach taken involved the interaction of three different FLAG-tagged 
versions of Mpk1/Slt2 – WT, inactivated Mpk1/Slt2 or catalytically inactive 
(“kinase-dead”) Mpk1/Slt2 with tagged Prs1,  
(iv) detailed investigation of the prs1∆prs5∆ synthetically lethal strain rescued 
by WT PRS1 and various in vitro-generated mutated versions of PRS1 in 
an attempt to determine the cause of synthetic lethality as demonstrated 
by Rlm1 expression and the phosphorylation status of Mpk1/Slt2 before 
and after exposure to mild heat shock and 
(v) examining the functionality of the three postulated phosphorylatable 
residues of Prs5 as demonstrated by the transcriptional readouts, Rlm1 
and Fks2, of the CWI pathway. 
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2 Materials and Methods 
All chemicals used are of analytical grade and were purchased from Thermo Fisher 
Scientific (Loughborough, UK) or Sigma-Aldrich (Gillingham, UK) unless otherwise 
stated. All chemicals were handled and stored under conditions recommended by 
the suppliers and according to the University regulations. COSHH forms were 
completed as required.  
 
2.1 Strains 
Table  2.1: S. cerevisiae strains used in this study 
 
 
Strain 
                 
          Genotype 
    
   Sources 
 
 
YN94-1 
 
MATa  ade2-1 his3-11 leu2-3,112 trp1-1 ura3-1 
can1-100 ssd1-d2 GAL (original strain) 
  
Hernando et al. (1999) 
YN96-65 YN94-1 prs1∆::loxP  Carter et al. (1997) 
YN96-68       YN94-1 prs5Δ::loxP  This study 
 YN96-68 [pHPS100-Ura, pGAD424]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-Prs5]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-prs5(479)]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-prs5(362.2)]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-prs5(365.5)]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-prs5(365.1)]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-prs5(S364A)]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-prs5(S367A)]  This study 
 YN96-68 [pHPS100-Ura, pGAD424-prs5(S369A)]  This study 
YN96-77     YN94-1 prs3∆::loxP  Laboratory collection 
YN97-5     YN94-1 prs4∆::loxP  Laboratory collection 
YN97-14 YN94-1 prs1∆::HIS3 prs5∆::loxP [pVT1]   Hernando et al. (1999) 
 YN97-14 prs1∆::HIS3 prs5∆::loxP [pGBT9-Prs1]  This study 
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Table 2.1:  (continued) 
 
 
 
 
 
 
 
 
 
Strain 
                 
          Genotype 
    
   Sources 
 
 YN94-1 prs1∆::HIS3 prs5∆::loxP [pGBT9-
prs1(L115T)]    
YN94-1 prs1∆::HIS3 prs5∆::loxP [pGBT9-
prs1(Q133P)]  
YN94-1 prs1∆::HIS3 prs5∆::loxP [pGBT9-
prs1(D326A)]    
YN94-1 prs1∆::HIS3 prs5∆::loxP [pGBT9-
prs1(H130A/D326A)]    
Ugbogu et al. (2013) 
 
Ugbogu et al. (2013) 
 
Ugbogu et al. (2013) 
 
Ugbogu et al. (2013) 
 
YN97-91 YN94-1 prs2∆::loxP prs4∆::loxP prs5∆::loxP 
[pYES-DEST52-PRS5-His6X-V5::URA3] 
This study 
 
YN97-96 YN94-1 prs1∆::GFP-PRS1    Schneiter et al. (2000) 
YN97-157     YN97-96 prs2∆::GFP-PRS1    Schneiter et al. (2000) 
YN98-8 YN97-96 prs2∆::GFP-PRS1    Schneiter et al. (2000) 
YN98-11 YN97-96 prs3Δ::kanMX4-IoxP    Schneiter et al. (2000) 
YN11-01 YN94-1 prs5Δ::kanMX4-loxP  [pYES-DEST52-
PRS5-His6X-V5::URA3] 
   This study 
YN98-12 YN97-96 prs4Δ::kanMX4-IoxP   Schneiter et al. (2000) 
YN98-14 YN97-96 prs5Δ::kanMX4-loxP   Schneiter et al. (2000) 
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2.2 Plasmids 
 
Table 2.2: Plasmids 
   
Plasmid 
            
         Description 
              
    Sources 
  
 
pGBT9 
 
GAL4 DNA-binding domain cloning 
vector. TRP1 is the selectable marker. 
    
  Laboratory collection 
pGBT9-Prs1 A Y2H vector in which the PRS1 
coding region was fused to the DNA-
binding domain of GAL4.  
  Hernando et al. (1999) 
pGBT9-prs1(L115T) A mutated version of PRS1 created by 
in vitro mutagenesis to convert the 
leucine (L) residue at 115 to threonine 
(T). 
  Laboratory collection 
pGBT9-prs1(Q133P)  
 
A mutated version of PRS1 created by 
in vitro mutagenesis to convert the 
glutamine (Q) residue at 133 to proline 
(P). 
  Laboratory collection 
pGBT9-prs1(D326A)  
 
A mutated version of PRS1 created by 
in vitro mutagenesis to convert the 
aspartate (D) residue at 326 to alanine 
(A). 
  Laboratory collection 
pGBT9-
prs1(H130A/D326A)  
 
A doubly mutated version of PRS1 
created by in vitro mutagenesis to 
convert the histidine (H) residue at 130 
to alanine (A) and the aspartate 
residue (D) at 326 to alanine (A). 
  Laboratory collection 
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Table  2.2:  (continued) 
   
Plasmid 
       
           Description  
         
      Sources 
 
 
pVT1 
 
2-micron-based vector derived from 
pVT100-Ura containing a 1346-bp 
fragment that corresponds to the 
PRS1 coding sequence plus 42 and 
21 bp upstream and downstream. 
URA3 is the selectable marker. 
  
 Hernando et al. (1999) 
pGBT9-Prs5 
 
A Y2H vector, in which PRS5 was 
fused to the DNA-binding domain of 
GAL4.  
 Hernando et al. (1999) 
pGAD424 A GAL4 activation domain cloning 
vector. LEU2 is the selectable marker. 
  Laboratory collection 
pGAD-Prs3 
 
A Y2H vector, in which PRS3 was 
fused to the GAL4 activation domain. 
 
  Laboratory collection 
pGAD-Prs5 
 
A Y2H vector, in which PRS5 was 
fused to the GAL4 activation domain.  
   Hernando et al. (1999) 
pGAD-prs5(479)     A triply mutated version of PRS5 
created by in vitro mutagenesis to 
convert the serine (S) residues at 364, 
367 and 369 to alanine (A).  
   Laboratory collection 
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Table 2.2: (continued) 
   
Plasmid 
     
           Description  
         
  Sources 
 
 
pGAD-prs5(362.2) 
 
 
A sextuply mutated version of PRS5    
created by in vitro mutagenesis to 
convert the threonine residues at 362, 
363, 365 in pGAD-prs5(479) to alanine 
(A). 
  
 
Laboratory collection 
 
pGAD-prs5(365.1) 
 
A sextuply mutated version of PRS5 
created by in vitro mutagenesis to 
convert the threonine (T) residues at 
365 and 368 to alanine (A) and the 
serine (S) residue at  366 to alanine  
(A) in pGAD-prs5(479). 
 Laboratory collection 
 
pGAD-prs5(365.5)  
 
A spontaneous deletion of PRS5 
arising during in vitro mutagenesis in 
which 16 bp were removed causing 
the reading frame to be altered and 
resulting in a truncated version of Prs5 
terminating 19 aa downstream of the 
deleted region.  
 Laboratory collection 
pHPS100-Ura A centromeric vector carrying a 3.2 kb 
LexA-RLM1∆N construct under the 
control of the ADH1 promoter and the 
lacZ reporter gene proceeded by five 
LexA-binding sites. URA3 as the 
selectable markers. For measurement 
of Rlm1 transcriptional activation. 
 Kirchrath et al. (2000) 
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Table 2.2:  (continued) 
   
Plasmid 
      
          Description  
         
           Sources 
 
   pHPS100-Leu 
 
A centromeric vector carrying a 3.2 
kb LexA-RLM1∆N construct under 
the control of the ADH1 promoter 
and the lacZ reporter gene 
proceeded by five LexA-binding 
sites. LEU2 as the selectable 
marker. For measurement of Rlm1 
transcriptional activation. 
 
     Kirchrath et al. (2000) 
  p2313  YEp351[Slt2-FLAG], a high copy    
number expression vector of Slt2 
with a C-terminal FLAG epitope (D-
Y-K-D-D-D-K).  
    Kim et al. (2007) 
  p2316    YEp351[slt2(T190A,Y192F)-FLAG], 
a high copy number expression 
vector containing a C-terminally 
FLAG-tagged version of Slt2 doubly 
mutated at T190 and Y192 which 
can no longer be phosphorylated. 
     Kim et al. (2008) 
  p2317  YEp351[slt2(K54R)-FLAG], a high 
copy    number expression vector 
containing a C-terminally FLAG-
tagged version of Slt2 mutated at 
K54R which expresses an 
enzymatically inactive form of Slt2.  
    Kim et al. (2008) 
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Table 2.2:  (continued) 
   
Plasmid 
       
      Description  
         
             Sources 
 
pYESDEST52 
 
Contains a LR cloning site flanked by 
a V5-His6X C-terminal tag under the 
control of the GAL1 promoter. 
  
    Life Technologies 
pYESDEST52-
PRS5-
His6XV5::URA3 
A fusion protein of Prs5 with a V5-
His6X C- terminal tag. URA3 is the 
selectable marker. 
   Fasolo et al. (2011) 
pBG1805 An in frame fusion of PRS1 with a C-
terminal affinity tag consisting of 
6xHis, HA, and 3C protease under 
the control of GAL1 promoter. URA3 
is the selectable marker. 
   Open Biosystems 
pFKS2-lacZ Contains a lacZ gene from E. coli 
under the control of the FKS2 
promoter region between nts -701 
and -1. URA3 is the selectable 
marker. 
   de Nobel et al., 
(2000a) 
 
The phenotypes of strains stored as glycerol stocks were checked before use by 
streaking on appropriate media (cf. 2.3 & 2.4). All plasmids used were checked by 
sequencing.  
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2.3 Media 
2.3.1 LB (Luria-Bertani) medium 
10.0 g Tryptone 
5.0 g Yeast extract   
10.0 g NaCl  
15.0 g Agar (if plates are required) 
Made up to 1 litre with distilled H2O and autoclaved at 121C for 15 min. For Amp
R 
selection, ampicillin was added to a final concentration of 100 g/ml when the media 
had cooled to approximately 55C. 
 
2.3.2 YEPD (Yeast Extract Peptone Dextrose) medium 
20.0 g Glucose (Formedium Ltd, UK) 
10.0 g Yeast extract  
20.0 g Bacteriological peptone  
20.0 g Agar (if plates are required) 
Made up to 1 litre with distilled H2O and autoclaved at 121C for 15 min.  
 
2.3.3 SC (Synthetic Complete) media 
 20.0 g Glucose   
 1.70 g Yeast nitrogen base-without amino acids and ammonium sulphate 
 5.0 g Ammonium sulphate 
 25 ml Amino acid+adenine+uracil mix (see below) 
 20.0 g Agar (if plates are required)  
 Made up to 1litre with distilled H2O and autoclaved at 121C for 15 min.  
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‘Amino acid + Adenine + Uracil’ drop-out mix (40x):   
0.10 g Adenine (hemi-SO4)         0.20 g L-Arginine                   0.10 g L-Histidine 
0.60 g L-Isoleucine                      0.60 g L-Leucine                   0.40 g L-Lysine 
0.10 g L-Methionine                     0.60 g L-Phenylalanine         0.60 g L-Threonine     
0.40 g L-Tryptophan                    0.10 g Uracil 
  
Made up to 100 ml with distilled H2O. ‘Drop-out’ mixes lacking the relevant 
component(s) were used for selective media. 
 
2.3.4 Raffinose media 
1.70 g Yeast nitrogen base-without amino acids and ammonium sulphate 
(Formedium Ltd, UK) 
 5.0 g Ammonium sulphate 
25 ml ‘‘Amino acid + Adenine-Uracil’’ drop-out mix (2.3.3) 
20% (w/v) raffinose (Formedium), autoclaved  
Made up to 900 ml with distilled H2O and autoclaved at 121C for 15 min.  100 ml 
20% (w/v) raffinose was added to 900 ml SC-Ura after the media had cooled to 
approximately 50oC to give a final concentration of 2% raffinose.  
 
2.3.5 3xYeast Extract Peptone Galactose (YEPG) media 
3.0 g Yeast extract  
6.0 g Peptone 
6.0 g Galactose 
Made up to 100 ml with distilled H2O and autoclaved at 121C for 15 min.  
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2.4  Strain maintenance (Guthrie and Fink, 1991, Ausubel et al., 1995) 
For long-term storage at –70°C yeast strains were stored in YEPD media with 25% 
glycerol. To prepare glycerol stock cultures of S. cerevisiae, a fresh colony was 
picked from a YEPD plate and cells were re-suspended in 500 μl YEPD medium, in a 
2 ml screw-cap tube (Fisher Scientific, UK). The tubes were then vortexed vigorously 
to thoroughly disperse the cells and 500 μl of sterile 50% (v/v) glycerol (Sigma-
Aldrich) was added to the suspension to give a final glycerol concentration of 25% 
(v/v).  For preparation of ‘working’ stock plates, a portion of the frozen glycerol stock 
was streaked onto YEPD or appropriate SC agar plates and incubated at 30°C.  
When a mid-log phase culture was required, an appropriate amount of an o/n culture 
was transferred into the relevant medium to give a cell suspension with an OD600 of 
approximately 0.2-0.3 and incubated at 30°C for 3-5 hr with shaking (170 rpm, 
GallenkampTM, Heraeus Instruments) to give a culture with an OD600 of 0.4-0.6.  
Transformed S. cerevisiae strains were stored on appropriate SC ‘drop-out’ media to 
maintain selective pressure on the plasmid. 
 
2.5 Determination of cell density 
The absorbance of a culture was determined spectrophotometrically at 600 nm 
(SmartSpec™ 3000, Bio-Rad). For reliable measurements, the culture was diluted to 
ensure the measured optical densities (OD) are not greater than 1. For S. cerevisiae, 
the OD600 = 1.0 is equivalent to 310
7 cells/ml (Groves et al., 1996).  
Log phase growth of the yeast can be divided into three stages. Early-log phase was 
the period when the cell density is less than 107 cells/ml, mid-log phase is between 
1-5107 cells/ml and late-log phase occurred when the cell density was between 5 
107- 2108 cells/ml.  
 
2.5.1 Sorbitol rescue of yeast strains’ sensitivity to temperature and caffeine 
A single colony of S. cerevisiae cells was inoculated in 10 ml appropriate medium at 
30oC o/n with shaking.  The OD600 of the o/n culture was determined as described 
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above and adjusted to OD600 0.5 followed by 10-fold serial dilutions (10
-1-10-4). To 
test for temperature and caffeine sensitivity or ability of sorbitol to rescue impaired 
growth 3 µl aliquots of the individual serial dilutions were spotted onto appropriate 
solid media with or without caffeine in the presence or absence of 1 M sorbitol 
(Formedium) at the indicated concentrations and incubated at 30oC or 37oC for 3 
days. Growth at 30oC was routinely used as the control. 
 
2.6  Yeast transformation using the ‘PLATE’ method (Elble, 1992) 
Solutions: 
Plate solution: 90 ml 45% (w/v) PEG 4000 (Fluka Chemicals, Switzerland) 
 10 ml 1 M LiOAc 
 1 ml 1 M Tris-HCl, pH 7.5 
 0.2 ml 0.5 M EDTA, pH 8.0 
 
Carrier DNA: Herring sperm DNA (10 mg/ml).  
10 ml distilled H2O was added to 100 mg of herring sperm DNA and briefly vortexed. 
The mixture was boiled for 15 min and snap-cooled on ice for a further 15 min. The 
DNA was then sheared by repeated passage through a 20-gauge needle (Fisher 
Scientific, UK). The mixture was then boiled for an additional 15 min, aliquoted and 
stored at -20C 
 
Protocol: 
The yeast strain of choice for transformation was streaked out for single colonies 
onto YEPD or appropriate selective media and incubated o/n at 30C. A single 
colony was picked and grown o/n in 10 ml of the same media at 30C with shaking 
(170 rpm).  0.5 ml of the culture was spun down in a microcentrifuge (Eppendorf 
5415D, 1.0R, HeraeusTM Instruments) at 13000 rpm for 2 min and the supernatant 
was decanted by inversion. 10 l of carrier DNA (100 g) and 1 g transforming DNA 
were then added (no transforming DNA was added for control) and vortexed. 0.5 ml 
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PLATE solution was added to the reaction mixture, vortexed and incubated o/n at 
RT. Cells were then pelleted at 13000 rpm for 2 min, washed and re-suspended in 
100 l sterile distilled H2O. This was then plated directly onto selective media and 
incubated at 30C for 3 days. 
 
2.7 Preparation of crude extract from S. cerevisiae 
Solutions: 
Glass bead disruption buffer: 0.02 M Na-phosphate, pH 7.4 
 0.5 M NaCl 
 0.001 M PMSF 
 
1 mM PMSF (a 100 mM stock solution was prepared in isopropanol and stored at -
20 °C). 
I tablet of protease inhibitor for each 10 ml glass bead disruption buffer (Roche 
Diagnostic, Germany). 
425-600 μm acid-washed glass beads. 
 
Protocol:  
Single colonies of the yeast strains to be transformed were re-streaked onto 
appropriate fresh media and incubated at 30oC for 3 days. A single colony from the 
fresh plate was then grown o/n in 10 ml of YEPD at 30oC with gentle shaking (170 
rpm). The cells were then diluted to the OD600 ≈ 0.2 in 50 ml of the selective media in 
250 ml ErlenmeyerTM flasks and incubated at 30oC and 170 rpm until OD600 ≈ 1-1.2 
was attained. The cells were harvested in 50 ml GreinerTM tubes using a pre-cooled 
centrifuge (Megafuge 1.0R, Heraeus Instruments) at 3000 rpm for 5 min at 4oC, 
followed by washing twice with ice-cold H2O. The wet weight of the cells was 
determined and the cells were frozen at -80oC. The cells were lysed using 1 ml of 
glass bead disruption buffer containing I tablet of protease inhibitor with an equal 
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volume of 425-600 μm glass beads in a 50 ml Greiner tube. The suspension was 
vortexed for 1 min and ice-cooled for 1 min. This process was repeated 7x and an 
aliquot of the vortexed (broken) cells and intact (unbroken) cells viewed under the 
microscope (Zeiss Axiovert25R) to check for breakage. The lysed cells were 
centrifuged at 3000 rpm for 5 min at 4oC (Megafuge 1.0R) and the supernatant 
decanted to a fresh tube. The pellet was re-suspended with 0.5 ml glass bead 
disruption buffer and vortexed twice followed by centrifugation. The two supernatants 
were combined and the protein concentration determined according to Bradford 
(1976). 
 
2.8  Determination of total protein in cell extracts (Bradford, 1976) 
Solutions: 
Bovine Serum Albumin (BSA) standard solution (1.45 mg/ml, Bio-Rad) was re-
suspended in 20 ml ultrapure H20; this solution was then diluted to 100 μg/ml 
working solution by adding 1853 μl distilled H2O to 147 μl BSA standard solution. 
Protein assay dye reagent (Bio-Rad, #500-0006). 
Protocol: 
A standard curve was obtained by pipetting together the solution volumes listed in 
Table 2.3.  The concentration range was from 0-16 μg/ml BSA and the final volume 
of all samples was 1 ml.  200 μl of the dye reagent was mixed with 800 μl of each 
BSA dilution in a 1 ml disposable cuvette (Fisher Scientific, Fisher brand, #FB55147) 
and incubated at RT for 10 min.  The OD595 was then measured for each sample and 
the values were used to generate the calibration curve shown in Figure 2.1.  
For each protein sample three dilutions (1:100, 1:500 and 1:1000) were prepared in 
1 ml final volume with distilled H2O.  800 μl of each dilution was mixed with 200 μl of 
the dye reagent and incubated for 10 min at RT.  The protein concentration of the 
test samples was then determined and calculated from the standard curve taking into 
account the dilution factor. 
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Table 2.3: Composition of SDS-PAGE gels 
  
BSA concentration 
       (μg/ml) 
 
Volume of BSA working solution (ul)   
(100 μg/ml)  
       
             
          Dist.H2O  
               (μl) 
     0                        -               800 
     2                       20               780 
     4                       40               760 
     6                       60               740 
     8                       80               720 
    10                      100               700 
    12                      120               680 
    14                      140               660 
    16                      160               640 
    18                      180               620 
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Figure 2.1: Standard curve for quantifying total protein content in cell extracts, using BSA as the standard 
Aliquots of known amounts of BSA ranging from 0-16 μg were incubated for 10 min at RT with Bradford reagent and the absorbance measured at 595 nm. 
Means of triplicate determinations were used to plot the curve above. The protein content of experimental samples was calculated using the equation, x = a/y, 
of the standard curve and taking into consideration the dilution factor. 
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2.9  Analysis of proteins by SDS-polyacrylamide gel electrophoresis (SDS- PAGE) 
(Laemmli, 1970) 
Solutions:  
4x separating gel buffer:                  1.5 M Tris-HCl, pH 8.8 
 10% (w/v) SDS 
 
4x stacking gel buffer: 0.5 M Tris-HCl, pH 6.8 
 10% (w/v) SDS 
 
1x electrophoresis buffer:  25 mM Tris-base 
 192 mM glycine 
 0.1% (w/v) SDS 
 pH should be between 8.1-8.3 
 
2x  Laemmli sample buffer: 0.125 M Tris-HCl, pH 6.8 
 4% (w/v) SDS 
 5% (v/v) β-mercaptoethanol 
 20% (v/v) glycerol 
 0.01% (w/v) bromophenol blue 
           
                                                                                                 
10% Ammonium persulphate (APS) 
TEMED (N, N, N', N'-tetramethylene-ethylenediamine, Bio-Rad) 
t-amyl ethanol (≥99%) 
Protein markers:  
Broad range pre-stained protein marker (Thermo Fisher Scientific, #sm1811). The 
marker is a -3-colour ladder with 10 proteins covering a molecular weight range from 
10-170 KDa. The ladder contains two bright orange reference bands at 72 KDa and 27 
KDa for easy band referencing and blot orientation.                          
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Broad range pre-stained marker (Bio-Rad, #161-0376). The marker consists of 10 
distinct bands with a molecular range from 10-250 KDa. The 25 and 75 KDa bands are 
stained orange. 
Precision ProteinTM Strep Tactin-HRP conjugate (Bio-Rad, #161-0380). The pre-stained 
marker contains 10 distinct bands with a molecular range from 10-250 KDa and is 
detectable using WesternCTMblotting detection reagent which recognizes Precision Plus 
ProteinTM WesternCTM Standards and enables simultaneous detection of protein 
standards and sample proteins. 
All working solutions were stored at 4 °C except for the loading buffer which was stored 
in 0.5 ml aliquots at -20 °C.  APS was prepared immediately prior to use. 
 
2.9.1    Preparation of gels for SDS-PAGE 
The plates were washed with distilled H2O, rinsed with ethanol, dried and assembled 
according to the manufacturer’s instructions (1 mm thick, Mini-Protean Cell®, Bio-Rad).  
Unless pre-cast gels obtained from Bio-Rad were used, a 10% separating gel was 
prepared in a 100 ml Erlenmeyer flask (Table 2.4) and introduced carefully into the gel 
sandwich using a 1 ml pipette to about 1.0 cm from the top of the front plate. The 
surface was overlaid by adding t-amyl ethanol to remove air bubbles and the gel was 
allowed to polymerize for 45 min at RT. The ethanol was poured off and the gel 
sandwich rinsed with distilled H2O.  A 5% stacking gel solution (Table 2.4) was then 
poured onto the separating gel and the comb carefully inserted without trapping air 
bubbles. The gel was allowed to polymerize for 30 min at RT.  The gel sandwich was 
attached to the electrode assembly of the Mini-PROTEAN® Tetra Cell (Bio-Rad, #165-
3301) and inserted into the electrophoresis tank. 1x electrophoresis buffer (700 ml) was 
added to the inner and outer reservoirs of the electrophoresis chamber, the comb 
carefully removed and the wells rinsed thoroughly with Ix electrophoresis buffer.    
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Table 2.3: Standard curve samples for Bradford protein assay 
 
Solution  Separating gel 
  10% (20 ml) 
  
 Stacking  gel  
  5% (10 ml) 
 
40% acrylamide/0.8% bis-acrylamide 
stock solution         5 ml        1 ml 
4x separating or stacking gel buffer         5  ml        2.5 ml 
dist. H2O        10 ml        6.4 ml 
TEMED         20 μl        10 μl 
APS 10% (added last)        200 μl   100 μl 
  
 
2.9.2   Preparation of protein samples 
25 or 50 μg of crude extract, as determined by the Bradford assay (Bradford, 1976), 
was mixed with twice the extract volume of the 2x Laemmli sample buffer in a 1.5 ml 
Eppendorf tube.  Samples were then heated at 100 oC for 5 min and snap-cooled on ice 
and centrifuged for 1 min at RT in a microcentrifuge.  Samples were loaded by means 
of a HamiltonR syringe (Sigma-Aldrich, #20737 (100 µl)) into the rinsed wells of the gel. 
At least one well contained 5 μl of a standard pre-stained protein marker prepared 
according to the manufacturer’s instructions (Bio-Rad, #161-0376). Electrophoresis was 
carried out at 200 V (constant voltage) until the bromophenol blue dye reached the 
bottom of the separating gel. 
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2.9.3   Coomassie staining and destaining of the gel 
 
Coomassie Blue staining solution: 1% (w/v) Coomassie Blue R-250 
 45% (v/v) ethanol 
 10% (v/v) glacial acetic acid 
 45 ml distilled H2O 
 
Destaining solution:  40% (v/v) ethanol 
 10% (v/v) glacial acetic acid 
 50 ml distilled H2O 
 
The gels were soaked with gentle shaking (Mini Orbital Shaker SO5, Stuart Scientific) 
for 30 min in Coomassie Blue staining solution and were then transferred into the 
destaining solution.  The destaining solution was replaced at least 3x until the gel 
background was destained. Documentation of gels was performed with the Bio-Rad 
ChemiDocTM XRS+ imager. The gel was placed on the white light conversion screen 
inside the Universal Hood 11 and the Epi-illumination switched on. Once the gel is 
satisfactorily positioned an image is obtained by running the appropriate protocol from 
the Image Lab software V4.1 (Bio-Rad). Images are stored on the dedicated computer. 
 
2.10 Western blotting  
Solutions: 
1x transfer buffer: 25 mM Tris-base 
 192 mM glycine 
 
pH should be between 8.1-8.4 
 
1xTris-Buffered Saline (TBS): 20 mM Tris-HCl pH 7.5 
 
150 mM NaCl  
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TBS-T: 1xTBS + 0.1% Tween 20 
 
 
Blocking solution: non-fat dried milk (5% (w/v in TBS-T) 
 
 
Ponceau S staining solution: 0.5% (w/v) Ponceau S (Bio-Rad) 
 1% (v/v) glacial acetic acid 
         
                           
Methanol (100%) 
 
Kodak® processing chemicals for autoradiographic film: GBX developer/replenisher and 
GBX fixer/replenisher (Sigma-Aldrich, #P7167-56A). 
 
ECL+PlusTM Western blotting detection reagent (GE Healthcare, #RPN2132) detects 
only sample proteins transferred to the membrane while WesternCTM blotting detection 
reagent also recognizes Precision Plus ProteinTM WesternCTm Standards on account of 
the StrepTactin-HRP conjugate. 
 
2.10.1   Electroblotting on PVDF (polyvinylidene difluoride) membrane 
Electrotransfer of the separated proteins was performed using the Mini Trans-Blot® 
system from Bio-Rad. A PVDF sheet (GE Healthcare, Hybond-P™ 0.2 μm) was cut to fit 
the gel and pre-activated by soaking in 100% methanol for 30 sec.  After a 5 min rinse 
in distilled H2O, the membrane and the previously run SDS PAGE gel were equilibrated 
separately in pre-cooled 1x transfer buffer for 15-20 min with gentle shaking.  Two 
sheets of Whatman 3 MM paper and two fibre pads (Bio-Rad, #1703932) were also 
soaked in transfer buffer for preparation of the gel-membrane sandwich in a shallow 
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tray.  A frozen cooling unit (stored at -20°C) and a stirrer bar were placed into the tank 
filled with 1x transfer buffer (~ 900 ml). The sandwich cassette was inserted into the 
tank and the entire Trans-Blot apparatus placed on a magnetic stirrer (Fisher Scientific, 
#200042). The transfer was carried out at 100 V (constant voltage) for 1 hr. 
 
2.10.2   Immunodetection 
Immunodetection involves the transfer of proteins separated by SDS-PAGE from the 
gel onto a membrane which is subsequently probed with a specific primary antibody. 
Antibody/antigen interactions are detected by a secondary antibody which is coupled to 
the enzyme horseradish peroxidase (HRP). Addition of enzyme substrate results in a 
visible product at the location of the secondary antibody bound to the specific primary 
antibody/antigen complex. HRP-labelled antibodies catalyse the following reaction: 
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Figure 2.2: Chemiluminescent reaction of Lumigen PS-3 with horseradish 
peroxidase  
(taken from Amersham ECL Plus Western Blotting Detection Reagents, Product Booklet, Life Sciences, 
GE Healthcare).  
This reaction is based on the oxidation of Lumigen PS-3 Acridan substrate through a combined HRP and 
peroxide-catalysed reaction which generates thousands of acridinium ester intermediates per minute. 
These intermediates react with peroxide under slightly alkaline conditions to produce a sustained high 
intensity chemiluminescence with maximum emission at a wavelength of 430 nm. The resulting light is 
detected with the ChemiDoc
TM
 XRS+ imager. 
 
Blocking the membranes: 
All the incubation with antibodies and washing steps were carried out with gentle 
shaking at RT in a small square lidded container.  
Following the electro-transfer, the membrane was washed in 1xTBS-T for 5 min and the 
gel stained in Coomassie Blue R-250 to monitor the transfer efficiency. Alternatively, 
the membrane was reversibly stained with 0.5% Ponceau S staining solution and de-
stained in distilled H2O. Non-specific protein binding sites were blocked by incubating 
the membrane in 5% non-fat dried milk in 1xTBS-T for 1 hr at RT or o/n at 4oC, then the 
membrane was washed 2×2 min with 1xTBS-T. 
Lumigen PS-3 Acridan 
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Primary antibody incubation: 
Primary antibody incubation was performed by probing the blocked membrane for 1 hr 
with specific primary antibody at dilutions 1:1000 to 1:300,000 (depending on the 
amount of protein sample being investigated) in 1xTBS-T containing 5% non-fat dried 
milk. The membrane was then briefly rinsed with two changes of 1xTBS-T followed by 
soaking in 1xTBS-T for 5 min and then 6x 5 min washing in 1xTBS-T. 
FLAG primary antibody: monoclonal anti-FLAG M2 IgG1 produced in mouse (Sigma-
Aldrich, #F3165).  
GFP antibody: mouse monoclonal IgG1 (Santa Cruz, sc-73556). 
P-Slt2 antibody: rabbit polyclonal IgG (anti-phospho-pThr202/Tyr204, Santa Cruz, sc-
16982-R).  
Mpk1/Slt2 antibody: rabbit polyclonal IgG (Santa Cruz, sc-20168) 
His-probe antibody (H-3): mouse monoclonal IgG1 (Santa Cruz, sc-8036)  
Actin antibody: goat polyclonal IgG (C-11) (Santa Cruz, sc-1615). 
 
Secondary antibody incubation:  
The primary antibody was detected with secondary antibody used at different dilutions 
from 1:2000 to 1:100,000 (depending on the binding capacity of the primary antibody) 
incubated for 1 hr in 2% non-fat dried milk in 1xTBS-T. The membrane was then 
washed as described for the primary antibody.  
FLAG, GFP and His-probe secondary antibody: goat anti-mouse IgG1-HRP (Santa 
Cruz, sc-2060). 
P-Slt2 and Mpk1/Slt2 secondary antibody: goat anti-rabbit IgG-HRP (Santa Cruz, sc-
2004). 
Actin secondary antibody: donkey anti-goat IgG-HRP (Santa Cruz, sc-2020). 
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2.10.3   Image detection 
The washed membrane was placed on an acetate sheet for detection with the 
ECL+Plus™ system (Amersham Pharmacia Biotech) or the Westernc Bio-Rad detection 
kit. The detection reagents were mixed as described in the manufacturer’s instruction 
manual and pipetted onto the membrane. Following 3-5 min incubation at RT excess 
detection reagent was drained off by holding the membrane with forceps and touching 
the edge against a tissue. A second acetate sheet was put on top of the membrane and 
the whole sandwich placed into the ChemiDocTM XRS+ imager for analysis.  
 
For Western blots performed prior to acquisition of the ChemiDocTM XRS+ imager 
signals were obtained on X-ray film as follows: the membrane protected by two acetate 
sheets was placed into an X-ray film cassette with the protein side facing the light-tight 
seal of the cassette. In a dark room under red light, a sheet of autoradiographic film 
(Lumi-Film Chemiluminescent Detection Film 7.1x9.4 ins, Kodak®, #11666916001) was 
placed on top of the membrane for exposure times varying from 1-30 min, depending 
on the intensity of the signal.  
 
2.11  Co-immunoprecipitation 
2.11.1  Co-immunoprecipitation of GFP-Prs1 and FLAG-tagged Slt2 
Solutions: 
Lysis buffer: 50 mM Tris-HCl pH 7.5 
 150 mM NaCl 
 5 mM EDTA 
 5 mM EGTA 
 0.2 mM Na3VO4 
 50  mM KF 
 30  mM Na4P2O7 
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I tablet of protease inhibitor for each 10 ml lysis buffer (Roche Diagnostic, Germany). 
1 mM PMSF (a 100 mM stock solution was prepared in isopropanol and stored at  
-20oC. 
425-600 μm acid-washed glass beads 
RestoreTM Western Blot stripping buffer (Thermo Fisher Scientific, #21059). 
Western blotting solutions and techniques have been described in section (cf 2.10). 
 
1xTris-Buffered Saline (TBS): 20 mM Tris-HCl pH 7.5 
 150 mM NaCl 
 
 
Immunoprecipitation buffer I: 50 mM Tris-HCl pH 7.5 
 150 mM NaCl 
 5 mM EDTA 
 5 mM EGTA 
 0.2 mM Na3VO4 
 50  mM KF 
 30  mM Na4P2O7 
 1% NP-40 
 
Immunoprecipitation buffer II: 50 mM Tris-HCl pH 7.5 
 150 mM NaCl 
 5 mM EDTA 
 5 mM EGTA 
 0.2 mM Na3VO4 
 1% NP-40 
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Buffer M: 25 mM MOPS (pH 7.5) 
 1 mM EGTA 
 0.1 mM Na3VO4 
 15 mM C6H6NO6P 
 
Kinase buffer: 25 mM MOPS (pH 7.5) 
 1 mM EGTA 
 0.1 mM Na3VO4 
 15 mM C6H6NO6P 
 25 mM MgCl2 
 
 
2x Laemmli sample buffer w/o β-mercaptoethanol: 0.125 M Tris-HCl, pH 6.8 
 4% (w/v) SDS  
 20% (v/v) glycerol 
 0.01% (w/v) bromophenol blue 
 
ANTI-FLAG M2 affinity gel (Sigma-Aldrich, #A2220) is a purified murine IgG1 
monoclonal antibody covalently attached to agarose by hydrazide linkage. It is used for 
immunoprecipitation of FLAG fusion proteins (FLAG octapeptide: (D-Y-K-D-D-D-K). 
Protocol: 
A single colony, each of YN97-96 [p2313], YN97-96 [p2316] and YN97-96 [p2317], 
were re-streaked onto a fresh SC-Leu plate and incubated at 30 oC for 3 days. A single 
colony from each plate was inoculated into 10 ml of SC-Leu and incubated o/n at 30 oC 
with shaking. The cells were then diluted to OD600 ≈ 0.3 in four 250 ml Erlenmeyer 
flasks, each containing 50 ml SC-Leu and incubated at 30 oC at 170 rpm until OD600 ≈ 
0.7 was reached. Two flasks per culture were then transferred to 37oC and incubation 
continued for 1 hr. Cells were harvested in 50 ml GreinerTM tubes using a pre-cooled 
centrifuge (Megafuge 1.0R) at 3000 rpm for 5 min at 4oC, followed by washing twice with 
ice-cold H2O. The wet weight of the cells was determined and the cell pellets stored at -
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80oC prior to use. The cells were lysed using 1 ml lysis buffer with 1 ml of 425-600 μm 
glass beads in a 50 ml Greiner tube by vortexing for 1 min and ice-cooled for 1 min. 
This process was repeated 7x. The tubes containing the lysed cells were then 
centrifuged at 3000 rpm for 5 min at 4 oC and the supernatant decanted into a fresh 
Eppendorf tube for a second centrifugation at 13000 rpm for 10 min and the 
supernatant decanted into a fresh Eppendorf tube. Protein concentration of the 
supernatant was determined using the Bradford method (Bradford, 1976). 
The ANTI-FLAG M2 affinity gel was thoroughly re-suspended in order to make a 
uniform suspension of the resin and immediately 40 µl of the gel suspension was 
transferred into a 1.5 ml Eppendorf tube and the resin centrifuged at 1000 rpm for 30 
sec at RT. The resin was allowed to settle in the tube for 2-3 min and the supernatant 
removed from the resin with a narrow pipette tip. The packed gel was then washed 
twice with 0.5 ml 1xTBS and once with immunoprecipitation buffer I. Cell extract (250 
µg of protein) was added to immunoprecipitation buffer I to a final volume of 0.5 ml. This 
mixture was incubated in the cold room for 2 hr on a roller drum (Model TC-7, New 
Brunswick Scientific Co. Inc, USA) at a speed of 1000 rpm. Following centrifugation the 
pellet obtained was washed 4x with immunoprecipitation buffer II, twice with buffer M 
and once with kinase assay buffer. All washing was done by re-suspending the beads 
with the pipette tip before centrifuging for 30 sec for 1000 rpm. 60 µl Laemmli sample 
buffer w/o -mercaptoethanol was added to each sample, then heated at 100 oC for 5 
min and snap-cooled on ice for 1 min.  Samples were centrifuged at 1000 rpm for 30 
sec to pellet the FLAG beads and the supernatant transferred into a fresh Eppendorf 
tube and centrifuged at 13000 rpm for 1 min. 10 µl of each sample was loaded into the 
wells of two 4-20% pre-cast SDS-PAGE gels (Mini-ProteanR TGXTM, Bio-Rad, #456-
1093) rinsed with 1x electrophoresis buffer. One well contained 5 μl of standard pre-
stained protein marker prepared according to the manufacturer’s instructions (Bio-Rad). 
Both gels were run at the same time. Electrophoresis was carried out at a 200 V 
(constant voltage) for 50 min until the bromophenol blue dye reached the bottom of the 
separating gel. Each gel was transferred to a PVDF membrane; one membrane was 
incubated sequentially with anti-FLAG primary antibodies (1:300,000 dilution) and 
1:100,000 dilution of goat anti-mouse IgG1-HRP and the other membrane was 
incubated with anti-GFP antibodies diluted at 1:1000 primary antibody and 1:50,000 
anti-mouse IgG1-HRP secondary antibody. The membranes were treated with 
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WesternCTM blotting detection reagent Bio-Rad kit and images generated in the 
ChemiDocTM XRS+ imager.   
10 µg of each crude extract was also subjected to SDS-PAGE on a 4-20% pre-cast gel 
followed by Western blotting with either FLAG- or GFP-antibodies as described above 
to detect input for the co-immunoprecipitation procedure. 
 
2.11.2 Co-immunoprecipitation of His-tagged Prs1 and FLAG-tagged Slt2 
A single colony, each of YN96-65 [pBG1805-Prs1 + p2313], YN96-65 [pBG1805-Prs1 + 
p2316] and YN96-65 [pBG1805-Prs1 + p2317], was re-streaked onto a fresh SC-Ura-
Leu plate and incubated at 30oC for 3 days. A single colony from each plate was 
inoculated into 5 ml of SC-Ura-Leu and incubated o/n at 30oC with shaking. 1 ml of 
each of the o/n cultures was introduced into 25 ml SC-Ura-Leu+2% raffinose and 
incubated o/n at 30oC with shaking. The cells were then diluted to OD600 ≈ 0.3 in 9 x 
100 ml of SC-Ura-Leu+2% raffinose in 500 ml Erlenmeyer flasks incubated at 30oC at 
170 rpm until OD600 ≈ 1.2 was reached. Six flasks, two each for YN96-65 [pBG1805-
Prs1 + p2313], YN96-65 [pBG1805-Prs1 + p2316] and YN96-65 [pBG1805-Prs1 + 
p2317], were induced with 50 ml of 3 x YEP+2% galactose  and the three remaining 
cultures were not induced with 3 x YEP+2% galactose and served as the negative 
control. All cultures were incubated for 6 hr, after which three of the induced cultures 
were transferred to 37oC (New Brunswick Scientific Excella™ E25 temperature-
controlled shaker) for heat shock for 1 hr. The cultures were harvested by centrifugation 
at 3000 rpm for 5 min at 4oC (Megafuge 1.0R) and washed twice with ice-cold H2O.  The 
wet weight of the cells was determined and the cell pellets stored at -80oC prior to use. 
The cells of the individual cultures were then re-suspended in 1.5 ml lysis buffer and an 
equal volume of 425-600 μm acid-washed glass beads added and subjected to 
vortexing for 1 min and ice-cooled for 1 min. This process was repeated 7x. The tubes 
containing the lysed cells were then centrifuged at 3000 rpm for 5 min at 4oC and the 
supernatants decanted into a fresh EppendorfTM tubes, centrifuged at 13000 rpm for 15 
min and the supernatants decanted into fresh tubes. Protein concentration of the 
supernatants was determined using the Bradford method (Bradford, 1976).  
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Following the transfer of the electrophoresed immunoprecipitates the four membranes 
were washed in 1xTBS-T for 5 min and blocked by incubating in 5% (w/v) non-fat dried 
milk in 1xTBS-T for 1 hr at RT, The membranes were then washed 2×2 min with 
1xTBS-T. One membrane was incubated sequentially with anti-FLAG primary 
antibodies (1:150,000 dilution) and 1: 25,000 dilution of goat anti-mouse IgG1-HRP, the 
secondary antibody. The second membrane was incubated sequentially with anti-His 
antibody (H-3), diluted 1:1000 and a 1:25,000 dilution of the secondary antibody, goat 
anti-mouse IgG1-HRP. The third membrane was probed with anti-P-Slt2 (anti-phospho-
pThr202/Tyr204) as primary antibody (1:1000 dilution) and anti-goat-rabbit secondary IgG-
HRP antibody (1:5000 dilution). The fourth membrane was probed with actin IgG 
antibody (1:1000 dilution) and donkey anti-goat secondary IgG-HRP (1:10000 dilution). 
Incubation with primary and secondary antibodies was carried out for 1 hr each and 
washed 6x for 5 min in 1xTBS-T after each incubation. The membranes were treated 
with WesternCTM blotting detection reagent Bio-Rad kit (#170-5060) and visualized in 
the ChemiDocTM XRS+ imager (ChemiDocTM XRS+ imager, version 4.1, Bio-Rad) at 
varying times ranging from 0-10 min.   
10 µg of each of the crude extracts was also subjected to SDS-PAGE on a 4-15% gel 
followed by Western blotting with anti-FLAG, anti-His, anti-phospho-pThr202/Tyr204 or 
anti-actin antibodies as described above to detect input for the co-immunoprecipitation.  
 
2.12 Band quantification using the ChemiDocTM XRS+ Imager Quantity One”   
software  
After transferring the protein gel to a PVDF membrane and processing (Material and 
Methods, section 2.11.1) images were obtained with the ChemiDocTM XRS+ imager 
using the Image Lab software, V4.1 (Bio-Rad) for the detection of bands corresponding 
to the separated polypeptides. The intensity of the protein bands detected after 1 min 
exposure was quantified using the “Volume Tool” analysis as follows: rectangular boxes 
of equal size were drawn around each band using the rectangular button. The boxes 
were labelled U1, U2, U3, U4 etc. ‘U’ stands for ‘unknown’ to distinguish them from the 
‘Background’ volume. A rectangle of the same size is then drawn in the background 
area of the membrane. The value corresponding to the background pixels was 
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subtracted from the intensity of the detected bands. The background subtraction 
method was selected in the ‘Volume Report Option’ dialog box using ‘Global’ 
background subtraction which calculates and subtracts the background intensity for all 
detected bands to generate the ‘Adjusted’ volume. 
The relative quantity of the control signal was obtained by defining the number of the 
bands in a box area using the ‘Manual’ method, then double clicking the band at 30oC 
or 37oC to assign a ‘Reference’ volume for a specific band to generate the relative 
quantity of the controls. 
Finally the adjusted volumes obtained from the sample bands are divided by the relative 
quantity of the control bands at 30oC or 37oC to obtain the ‘Relative’ volume. The 
‘Relative’ volumes obtained are then plotted for each sample.  
 
2.13 Determination of β-galactosidase activity by the Thermo Scientific Yeast β-
galactosidase assay kit 
Solutions:                Y-PERTM Yeast Protein extraction reagent 
                                  2X β-galactosidase assay buffer 
                                  β-galactosidase assay stop solution (contains 1 M Na2CO3) 
Protocol: 
Three independent colonies of the appropriate strains were re-streaked individually onto 
fresh plates and incubated at 30oC for 3 days. A single colony from each plate was 
grown o/n in 10 ml of the respective media at 30oC with shaking at 170 rpm. The cells 
were then diluted to OD600≈ 0.3 in 2x50 ml of the relevant media in 250 ml Erlenmeyer 
flasks. One flask from each strain was incubated at 30oC and the other at 37oC until 
OD660 ≈1 was attained. The β-galactosidase assay buffer was thawed on ice and an 
equal volume of Y-PER reagent was added to make a 1:1 ‘working’ solution. A blank 
microcentrifuge tube was then prepared by mixing 350 µl of the culture medium (without 
cells), 350 µl ‘working’ solution and 300 µl β-galactosidase assay stopping solution. The 
remainder of the culture was placed on ice and retained for the preparation of crude 
extracts for Western blotting (cf. 2.10). 
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350 µl of each culture was transferred to an Eppendorf tube and an equal volume of the 
‘working’ solution was added to each culture. After mixing the Eppendorf tubes were 
incubated at 37oC in a water bath (Grant Instruments) until a pale yellow colour 
developed. The reaction was stopped by the addition of 300 µl stop solution and the 
samples vortexed for 15 sec before the reaction time was noted. The tubes were 
centrifuged at 13000 rpm for 30 sec to remove the cell debris and then the supernatant 
was transferred into a 1 ml disposable cuvette and the absorbance measured at 420 
nm against the sample blank.  
 
The following equation has been used to measure β-galactosidase activity is:  
 
                                 
           
            
 
                                           
t = reaction time (in minutes). 
V = volume of cells (ml) used in the assay. 
The factor 1000 takes into account the conversion from µl to ml. 
 
2.14 Determination of the FKS2 expression 
YN96-68 (prs5∆) was transformed with the vector (pGAD), pGAD-Prs5 (WT) or pGAD-
derivatives containing in vitro-generated mutations of PRS5 individually and the reporter 
plasmid pFKS2-lacZ (Table 2.2) by the ‘Plate’ method, described in section 2.7. The 
transformants were selected on Sc-Ura-Leu plates. Three independent colonies from 
each freshly re-streaked plate were used to inoculate o/n cultures in 10 ml SC-Ura-Leu 
media. After incubation the cells were diluted to OD600≈ 0.5 in 2x50 ml of SC-Ura-Leu in 
250 ml Erlenmeyer flasks. One flask from each strain was incubated at 30oC and the 
other at 37oC for 3 hr until OD660 ≈1 was attained. Fks2 expression was measured from 
the β-galactosidase reporter plasmid, pFKS2-lacZ, as described in section 2.14. 
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2.15   Preparation of cell extracts for isolation of His-tagged Prs5                  
(Fasolo et al., 2011)  
Fresh colonies of YN11-01 [pYESDEST52-PRS5-His6x-V5::URA3] and YN97-91 
[pYESDEST52-PRS5-His6x-V5::URA3] (cf. Table 2.1) strains were grown o/n in 50 ml 
SC-Ura+2% glucose at 30oC at 170 rpm for 24 hr. The cells were then diluted to an 
OD600 ≈ 0.1 in four flasks containing 400 ml SC-Ura+2% raffinose each and grown at 30 
oC at 170 rpm until an OD600 ≈ 0.6 was attained. The flasks were then induced with 200 
ml of YEP+2% galactose and incubated for a further 6 hr. The cells were harvested by 
centrifugation at 3000 rpm for 5 min at 4oC and washed twice with ice-cold H2O. The 
cells were then re-suspended in a 50 ml Greiner tube in 4 ml glass bead disruption 
buffer (as described in section 2.8) and an equal volume 0.425-600 μm acid-washed 
glass beads was added. The cells were lysed by eight cycles of vortexing for 1 min 
followed by 1 min incubation on ice. Cell breakage was monitored microscopically. The 
tubes containing the cell lysates were then centrifuged at 3000 rpm for 5 min at 4oC and 
the supernatant decanted to a fresh tube. The pellet was then re-suspended with 3 ml 
glass bead disruption buffer, then vortexed twice followed by centrifugation. The 
supernatant obtained was combined with the previous one and the pellets discarded. 
The protein concentration of each extract was determined according to (Bradford, 1976) 
and the supernatant stored at -80oC. 
 
2.16 Protein purification 
2.16.1 Protein purification using the ÄKTA purifier Avant 250 (Handbook from GE 
Healthcare, #11-0008-88 AF) 
The ÄKTA purifier is a fully automated liquid chromatography system designed for 
method development and research applications. The ÄKTA Purifier Avant 250  is a 
standard system unit consisting of two pumps (A & B), each with buffer selection 
valves, a mixer unit, in-line filter, injection valve, detectors and outlet selection valve 
and fraction collector. It has the following features: an easy pump wash for quick 
solvent exchange without disturbing the column and routine; an automated system 
wash, automatic on-line buffer preparation from stock solutions; on-line UV-detection of 
up to three wavelengths simultaneously; on-line monitoring of conductivity; on-line 
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monitoring of pH and fraction collection options ranging from microtitre plates to large 
vessels.  
Solutions: 
Binding buffer: 0.02 M Na-phosphate, pH, 7.4 
 0.5 M NaCl 
 
0.02 M imidazole, pH 7.4 
 
Elution buffer: 0.02 M Na-phosphate, pH, 7.4 
 0.5 M NaCl 
 
0.5 M imidazole, pH 7.4 
 
 
HisTrapTM FF column, 1 ml (GE Healthcare, # 11-0008-88 AF) 
Protocol: 
A sterile 1 ml syringe (Thermo Scientific, # 14-823-261) was filled with 1 ml distilled 
H2O.  After the stopper was removed from the HisTrap
TM FF column, 1 ml the syringe 
was connected to it and, to avoid the introduction of air bubbles, 1 ml distilled H2O was 
loaded drop-wise into the column. The snap-off end at the column outlet was then 
removed and connected to the adaptor (1/16 male) of the chromatography system and 
then ethanol was washed out of the ÄKTA purifier system with 3 to 5 column volumes of 
distilled H2O and the column equilibrated with 10 column volumes of binding buffer at a 
flow rate of 1 ml/min. The protein suspension was then applied to the column at a flow 
rate of 1 ml/min using a syringe fitted to the ‘Luerconnector’. After sample application 
the column was washed with 10 volumes of binding buffer at a flow rate of 1 ml/min and 
the His-tagged Prs5 protein eluted with a continuous gradient of 0% to 100% elution 
buffer in 20 column volumes at a flow rate of 1 ml/min.  
After elution of the His-tagged protein the column was washed with five column 
volumes of elution buffer followed by five column volumes of binding buffer and the 
column stored at -4oC for re-use. The ÄKTA Avant250 system (Handbook from GE 
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Healthcare, #18-1142-75 AD) was then washed with 20% ethanol in readiness for the 
next run. 
 
2.16.2 Manual purification of His-tagged Prs5 using a His SpinTrapTM column 
(Handbooks from GE Healthcare, #11-0036-91 AA) 
His SpinTrapTM  column (GE Healthcare, #28-4013-53) 
2-ml Eppendorf tubes and Eppendorf™ 5415D, 24 fixed-angle rotor centrifuge were 
used throughout the purification process.  
 
Solutions:     
Commercially available His buffer kit (GE Healthcare, #11-0034-00) and consisted of:                             
Binding buffer: 0.02 M Na-phosphate 
 0.5 M NaCl 
 
0.01 M imidazole, pH 7.4 
 
Binding buffer: 0.02 M Na-phosphate 
 0.5 M NaCl 
 
0.05-0.3 M imidazole, pH 7.4 
                                                           
(Handbook from GE Healthcare, #11-0036-91 AA). 
 
Protocol: 
The crude extracts prepared as described in section 2.17 were diluted 1:1 with binding 
buffer before applying to the His SpinTrapTM column. The column was inverted and 
shaken repeatedly to re-suspend the beads in the storage buffer. The top cap of the 
column was loosened by a one-quarter turn and after removing the snap-off end the 
column was placed in a 2-ml Eppendorf tube and centrifuged at 1000 rpm to remove 
the storage buffer. The cap was removed and the column equilibrated with 600 μl 
binding buffer followed by application of 600 μl of the sample added in ‘one-go’ and 
centrifuged at 1000 rpm for 30 s. The column was then washed twice with 600 μl 
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binding buffer by centrifugation at 1000 rpm for 30 s. The His-tagged Prs5 polypeptide 
was eluted by applying increasing imidazole in elution buffer ranging from 0.05-0.3 M 
imidazole to the column. The protein concentration was measured according to  
(Bradford, 1976) and subjected to SDS-PAGE and Western blot. 
 
2.17 Mass spectrometry analysis  
The samples for MS analysis were obtained by excision of a band identified by Western 
blotting as His-tagged Prs5 (section 3.18, Figure 3.28(b)) from a Coomassie-stained 4-
20% pre-cast SDS-Page gel. In addition, two discrete bands eluting with 200 mM 
imidazole but not cross-reacting with anti-His antibodies (result section, 3.18 Figure 
3.28(a)) were also excised from the gel. The three samples were stored at -80oC before 
dispatching to BMS Mass Spectrometry and Proteomics Facility at the University of St. 
Andrews where they were analysed by MALDI-TOF and interrogation of the NCBI 
protein database (http://www.ncbi.nlm.nih.gov/pubmed) identified specific peptide mass 
fingerprints.  
In a second experiment crude extracts of YN11-01 [pYESDEST52-PRS5-His6x-
V5::URA3] and YN97-91 [pYESDEST52-PRS5-His6x-V5::URA3] (cf. Table 2.1) were 
purified on His SpinTrapTM and subjected to 4-20% SDS-PAGE gel (1x1 mm) thickness 
gel. A ‘chunk’ approximately containing protein material ranging from 30 to 100 KDa 
from each His SpinTrapTM purified extract was analysed by ESI-QUAD-TOF at the 
University of St Andrews. The peptides obtained were used to interrogate the NCBI 
yeast database (http://www.ncbi.nlm.nih.gov/pubmed) and matched with the MASCOT 
search engine (https://bsrcmascot.st-andrews.ac.uk/mascot/x-cgi/ms-review.exe).  
 
2.18 Statistical analysis  
Statistical analysis was performed using One-way and Two-way analysis of variance 
(ANOVA) with the RTM Statistic software package, version 3.0.3. The normal distribution 
of the data and the homogeneity of variance were tested by Bartlett homogeneity test. 
Two-way ANOVA model (GLM) was developed to test the significance of the 
independent variables, plasmid and temperature and their interactions (plasmid x 
temperature). If the interaction term was significant simple effects within treatments 
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were investigated by One-way ANOVA with a Tukey test post-hoc to identify differences 
among groups. A p-value of ≤0.05 was considered statistically significant. 
 
2.19 Database searches  
The peptide search was performed with MASCOT (Version: 2.5.0) (Perkins et al., 1999) 
(www.matrixscience.com) using NCBI (http://www.ncbi.nlm.nih.gov/pubmed) and SGD 
(http://www.yeastgenome.org). Information on putative phosphorylation sites was obtained 
using the PhosphoGRID (Stark et al., 2010) (http://www.phosphogrid.org/) and 
PhosphoPep (Bodenmiller et al., 2008) (http://www.phosphopep.org/) databases 
available at SGD. 
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3 Results 
3.1 Monitoring the GFP signal generated by GFP-Prs1 in various PRS deletant 
strains 
At least one of the three minimal functional units which have been previously defined 
genetically as Prs1/Prs3, Prs2/Prs5 and Prs4/Prs5, each consisting of a Prs polypeptide 
with an NHR and one without, is necessary for the survival of S. cerevisiae (Hernando 
et al., 1998, Hernando et al., 1999). Genetic evidence and Y2H analysis data have 
shown the existence of two interacting functional complexes, Prs1/Prs3 or 
Prs2/Prs4/Prs5, with compensatory functions, since in the absence of one entity or a  
component thereof, the cell can still survive (Hernando et al., 1998, Wang et al., 2004). 
To extend these findings, an experiment was designed to gain more information on the 
S. cerevisiae PRPP synthetase complex(es) by means of biochemical evidence to 
confirm or refute the genetic evidence for the postulated enzyme complexes Prs1/Prs3 
and Prs2/Prs4/Prs5.  
Various PRS deletant strains containing a GFP-tagged PRS1 integrated at the PRS1 
locus (Schneiter et al., 2000) were monitored for the GFP signal. The PRS deletant 
strains, YN97-96 (prs1∆::GFP-PRS1), YN98-8 (YN97-96 prs2Δ), YN98-11 (YN97-96 
prs3Δ), YN98-12 (YN97-96  prs4Δ), YN98-14 (YN97-96 prs5Δ) were subjected to 
Western blot analysis and the results are shown in Figure 3.1. As expected, no GFP-
signal was visible in lane (2) since YN94-1 does not express GFP. However, the GFP-
Prs1 signal with an apparent molecular weight of 74 KDa is detectable in lanes (3-4 & 
6-7) but not in lane (5) which contains the extract of YN98-11 from which PRS3 has 
been deleted. The absence of the band in lane (5) may be due to the instability of Prs1 
in the absence of Prs3. The extract in lane (9) was prepared from YN98-11 (YN97-96 
prs3Δ) transformed with a plasmid-borne copy of PRS3, pGAD-Prs3, thus re-creating 
the WT situation. The extract of YN98-11 [pGAD-Prs3] contained the band 
corresponding to GFP-Prs1 whereas the extract in lane (8) which is YN98-11 [pGAD], 
showed no visible band of the same size as the GFP-Prs1 band. The lower MW signal 
in lanes (2–9) is that of an unknown protein recognized by anti-GFP antibodies and also 
appears in the negative control (lane (2)) and therefore may be regarded as a loading 
control. The results show that in the absence of PRS3, Prs1 is unstable (Ugbogu et al., 
2013). 
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Figure 3.1: Monitoring the GFP signal in YN94-1 (WT), YN97-96 (prs1∆::GFP-
PRS1), YN98-8 (YN97-96 prs2∆), YN98-11 (YN97-96 prs3∆), YN98-12 
(YN97-96 prs4∆) and YN98-14 (YN97-96 prs5∆).           
Whole cell extracts were prepared as described (Materials & Methods, section 2.7). 25 µg total protein of 
each of the crude extracts was separated on a 10% SDS-PAGE gel. The separated proteins were 
transferred to a PVDF membrane, blocked with 5% non-fat milk and incubated sequentially with anti-GFP 
antibodies diluted 1:1000 (sc-73556, primary antibody)  and a 1:50,000 dilution of anti-mouse IgG-HRP 
(sc-2060, secondary antibody). The membrane was treated with ECL detection solution (GE Healthcare) 
and exposed to X-ray film. 3 ng of commercially available recombinant GFP (rGFP) served as the 
positive control. The high MW signal corresponds to GFP-Prs1 and the lower MW signal in lanes (2-9) to 
an unknown protein which cross-reacts with anti-GFP antibodies and serves as a loading control. 
Western blots were performed on three biological replicates. A representative experiment is shown.  
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3.2 Growth of PRS deletant strains on 2% galactose at 30oC and 37oC 
Previous studies on growth characteristics of the WT and various prsΔ strains using 
YEPD solid media at elevated temperature have shown an impaired growth at 37oC for 
prs1Δ and prs3Δ strains (Wang et al., 2004). Hypersensitivity to caffeine of prs1Δ and 
prs3Δ strains and their ability to release more alkaline phosphatase than the WT strain 
have also been reported (Schneiter et al., 2000). The temperature and caffeine 
sensitivities of these strains may be due to an alteration in cell signalling mechanisms. 
With a view to obtaining more information on the phenotypic characteristics of PRS 
deletants, their growth was examined and compared with the WT strain by spotting 
YN94-1 (WT), YN96-65 (prs1Δ), YN97-157 (prs2Δ), YN96-77 (prs3Δ), YN97-5 (prs4Δ) 
and YN96-68 (prs5Δ) on YEP+2% galactose plates, incubating them for a period of 3 
days and documenting them on the second and third days. The reason for choosing 
galactose as the sole carbon source is that galactose-bound metabolites, e.g. UDP-
galactose, are involved in cell wall synthesis (Klis et al., 2002, Timson, 2007). As shown 
in Figure 3.2 the strains which are prs2Δ, prs4Δ or prs5Δ have a similar growth pattern 
to that of the WT at 30oC and 37oC. However, strains lacking PRS1 or PRS3 display 
distinctively slower growth at 30oC when compared to the other strains and growth is 
almost abolished at 37oC. This result may be interpreted to mean that in the absence of 
the Prs1/Prs3 complex galactose metabolism is impaired and is further evidence for the 
importance of the Prs1/Prs3 complex in cell metabolism. 
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Figure 3.2: Growth pattern of PRS deletant strains on YEP+2% galactose. 
The strains deleted for PRS1 (YN96-65), PRS2 (YN97-157), PRS3 (YN96-77), PRS4 (YN97-5) or PRS5 
(YN96-68) were grown in YEPD o/n. OD600 was determined and adjusted to OD600 = 0.5 for each culture. 
The cultures were serially diluted (10
-1
, 10
-2
, and 10
-3
 in sterile distilled H2O. 3 μl aliquots of each of the 
dilutions were spotted onto YEP+2% galactose and incubated
 
for 3 days and photographed after the 
second and third days.  
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3.3 The interaction of Prs1 with Slt2 as demonstrated by co-
immunoprecipitation 
Co-immunoprecipitation is one of the most powerful tools for detecting physical 
interactions between two or more proteins of interest by using target protein-specific 
antibodies which indirectly capture proteins of interest that are bound to the specific 
target protein. The basic approach to immuno-precipitating tagged proteins from whole-
cell extracts is illustrated below (Phizicky and Fields, 1995, Dwane and Kiely, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The coupled antibody (purple/grey) is a purified murine IgG monoclonal antibody covalently attached to 
resin beads by hydrazide linkage. The coupled antibody allows the tagged protein (antigen, red triangle) 
and any other protein(s) interacting with it (blue cylinder) to be precipitated from a mixture of specific and 
unspecific proteins (grey, green and yellow). The precipitated complex is then pelleted by centrifugation 
and washed to remove proteins which are not bound to the coupled antibody. The protein(s) of interest 
that bind to the coupled antibody, i. e. proteins interacting with the antigen is/are eluted and subjected to 
SDS-PAGE followed by Western blotting (taken from www.piercenet.com). 
 
 
 
  Cell lysate or 
Protein mixture 
       Incubation with 
Antibody-coupled Resin 
Coupled Antibody 
Antigen 
Protein interacting 
with Antigen 
Spin and wash Elute 
Analyse 
Figure 3.3: Principle of co-immunoprecipitation 
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3.3.1 Temperature-dependent interaction of Prs1 with Slt2 
It was previously shown by Y2H analysis that Prs1 interacts with Slt2, suggesting that at 
least one Prs polypeptide can interact with the CWI pathway (Wang et al., 2004). It was 
also observed that deletion of NHR1-1 of PRS1 completely abolished the Prs1/Slt2 
interaction whereas it has been reported that removal of NHR1-1 has no effect on the 
interaction of Prs1 with other Prs polypeptides (Carter et al., 1997, Wang et al., 2004). 
To exclude the possibility that the interaction of Prs1 and Slt2 was not a false positive 
(Vidalain et al., 2004, Bruckner et al., 2009), a result which can occur in Y2H, co-
immunoprecipitation was performed. Specifically, YN97-96 which contains an amino-
terminally GFP-tagged version of Prs1 (Schneiter et al., 2000) integrated at the PRS1 
locus was transformed with FLAG-tagged WT Slt2 and two mutated versions thereof. 
The FLAG-tagged versions of Slt2 were kindly provided by Dr. D. E. Levin, Boston 
University. Plasmid p2313 expresses a FLAG-tagged WT version of Slt2 and p2316 is a 
FLAG-tagged version of Slt2 mutated at positions T190 and Y192 and expresses a non-
activatable form of Slt2 which cannot be phosphorylated by Mkk1/Mkk2. Plasmid p2317 
has a mutation in the ATP binding site at position K54 of Slt2 and expresses an 
enzymatically inactive form of FLAG-tagged Slt2 (Kim et al., 2008). 
The FLAG-tagged versions of Slt2 were immuno-precipitated from crude extracts of the 
transformants YN97-96 [p2313], YN97-96 [p2316] and YN97-96 [p2317] grown at 30oC 
or exposed to mild temperature stress (37oC for 1 hr) as described in Materials and 
Methods, 2.11.1. The immuno-precipitated extracts were then subjected to incubation 
with anti-FLAG antibody to detect Slt2 or with GFP antibody to detect associated Prs1. 
As shown in Figure 3.4 for the crude extracts (CE), GFP-Prs1 and Slt2-FLAG signals 
are visible in lanes ((1-2), (7-8) and (13-14)). GFP-Prs1 co-precipitated with WT FLAG-
tagged Slt2 (p2313) at 30oC (lane (3)) and 37oC (lane (4)) with an increased GFP-Prs1 
signal under thermal stress conditions. However, the non-phosphorylatable version of 
Slt2 (p2316, slt2(T190A,Y192F)-FLAG) does not associate with Prs1 since there is no 
GFP signal in lanes (9-10). The kinase inactive version of Slt2 (p2317, slt2(K54R)-
FLAG) interacts with Prs1 only under thermal stress resulting in a strong signal (lane 
(16)) whereas no signal is visible at 30oC (lane (15)). No bands were detected when the 
extracts were incubated with protein A-affinity beads (no-antibody control, lanes ((5-6), 
(11-12) and (17-18)) and serve as the negative controls. 
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 Figure 3.4: Interaction of Slt2 with Prs1 
YN97-96 in which the endogenous PRS1 was replaced by the GFP-tagged Prs1 construct was 
transformed either with a high copy plasmid p2313 expressing WT Slt2-FLAG (WT) or a non-
phosphorylatable mutant, p2316 (slt2(T190A,Y192F)-FLAG (T190A Y192F) or the kinase inactive mutant, 
p2317 (slt2-K54R)-FLAG) (K54R). YN97-96 [p2313], YN97-96 [p2316] and YN97-96 [p2317] were grown 
in duplicate flasks to mid-log phase in SC-Leu at 30
o
C and one flask per strain was subjected to heat 
shock at 37
o
C for 1 hr. 10 µg of each crude extract (CE, lanes (1-2), lanes (7-8) and lanes (13-14) was 
prepared as described (Materials and Methods, section 2.7). For co-immunopreciptation 300 µg of each 
CE was treated as described in Materials and Methods, section 2.11.1 using FLAG (M2)-affinity beads or 
protein A-affinity beads (no-antibody control). The precipitates were washed with immunoprecipitation 
buffers and 10 l of each sample was subjected to electrophoresis on 4-15% SDS-PAGE gel and 
analysed by immunoblotting with anti-GFP and anti-FLAG antibodies. The GFP-Prs1 signal was 
detectable in lanes (3)-(4) and (16) whereas the Slt2 signal was detected in lanes (3-4), (9-10) and (15-
16) after the membrane was treated with ECL detection solution and visualized in the ChemiDoc XRS+ 
imager (ChemiDoc, version 4.1, Bio-Rad). No signals were detected in the protein A-treated extracts 
lanes ((5-6), (11-12) and (17-18)). Western blots were performed on three biological replicates and a 
representative blot is shown. 
 
 
For further verification that Slt2 interacts with Prs1 as observed in Figure 3.4, the 
experiment was repeated with a different set of transformed strains. The plasmid, 
pBG1805, an in-frame construct of Prs1 with a C-terminal affinity tag consisting of 
6xHis, HA, and 3C protease under the control of the GAL1 promoter (Materials and 
Methods, Table  2.2) was co-transformed into YN96-65 (prs1Δ) with the high copy 
plasmid expressing WT Slt2-FLAG (p2313), the mutant (p2316, slt2(T190A,Y192F)-
FLAG) or  (p2317, slt2(K54R)-FLAG). The strains were grown to OD600 ≈1.2 in SC-Ura-
Leu+2% raffinose and subsequently transferred into YEP+2% galactose for 6 hr at 30oC 
to induce expression of Prs1 and subjected to heat shock at 37oC for 1 hr (cf. Materials 
and Methods, section 2.11.2). 300 µg CE from the non-heat treated or heat treated-
cultures were used for co-immunoprecipitation. The CE and immuno-precipitated 
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extracts were subjected to SDS-PAGE and Western blotting (cf. Materials and Methods, 
sections 2.9.1 and 2.10). 
In the crude extract Prs1 was not detectable in Figure 3.5, lanes (1), (4) and (7) for WT 
Slt2-FLAG (p2313), mutant (p2316, slt2(T190A,Y192F)-FLAG) and (p2317, slt2(K54R)-
FLAG), respectively, as expected because they are un-induced cells and cannot 
express His-tagged Prs1 whereas a signal was observed when the cells were grown in 
galactose (lanes (2)-(3), (5)-(6) and (8)-(9)) which did not vary in intensity after heat 
shock (37oC). No signal was observed in CE (lanes (5) and (6)) when the membrane 
was challenged with anti P-Slt2 antibodies and confirms the elimination of the two 
phosphorylation sites in the activation domain of Slt2 in this mutant. A P-Slt2 signal was 
visible in CE of the WT and K54R mutant (lanes (2-3) & (8-9)), respectively. Slt2-FLAG 
was detected in every strain (lanes (1-9)) independent of galactose induction or heat 
shock thus indicating correct expression of Slt2-FLAG. The signal obtained for actin 
was detectable in all lanes and served as the loading control. 
The His-tagged Prs1 and P-Slt2 co-precipitated with either WT Slt2-FLAG (p2313) or 
(p2317, slt2(K54R)-FLAG), both of which showed an increased signal following 
galactose induction and heat shock (lanes (2)-(3) and (8)-(9)). However, as was the 
case for GFP-labelled Prs1 (Figure 3.4), there was no co-immunoprecipitation for Prs1 
and Slt2 with the non-phosphorylatable version of Slt2 (p2316) (lanes (5-6)) following 
galactose induction and heat shock. Since Prs1 failed to interact with the non-
phosphorylatable mutant of Slt2 (p2316), it is reasonable to postulate that Slt2 must be 
in the phosphorylated state in order to associate with Prs1. In agreement with this 
hypothesis Slt2 lacking kinase activity, (p2317, slt2(K54R)-FLAG), does interact with 
Prs1.  
Both co-immunoprecipitation approaches gave comparable results, although the 
versions of Prs1 used were either N-terminally labelled and integrated (Figure  3.4) or 
C-terminally tagged, galactose-inducible and plasmid-borne (Figure  3.5) versions. In 
summary the results obtained with either approach are consistent with the Prs1/Slt2 
interaction being dependent on the phosphorylation status of Slt2. 
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Figure 3.5: Phosphorylation status of Slt2 dictates its interaction with Prs1 
YN96-65 (prs1Δ) [pBG1805-Prs1] was transformed either with a high copy plasmid expressing WT [Slt2-
FLAG, (p2313)], [T190A, Y192F (slt2(T190A,Y192F)-FLAG), (p2316)] or [K54R (slt2(K54R)-FLAG), 
(p2317)]. The transformants were grown to an OD600 ≈1.2 in SC-Ura-Leu+2% raffinose and subsequently 
induced with YEP+2% galactose for 6 hr at 30
o
C in duplicate flasks to permit expression of Prs1 and then 
one flask was subjected to heat shock at 37
o
C for 1 hr. For co-immunoprecipitation 300 µg crude extract 
(CE) was treated as described in Materials and Methods, section 2.11.2 with FLAG (M2)-affinity beads to 
precipitate Slt2-FLAG. Western blotting with His-antibodies was used to detect Prs1, anti-FLAG 
antibodies detected Slt2 and the phosphorylation status of Slt2 (P-Slt2) was monitored by anti-phospho-
pThr
202
/Tyr
204
 antibodies (Materials and Methods, section 2.11.2). Western blots were performed on three 
biological replicates and representative membranes are shown. 
 
3.4   Phenotypes of rescued YN97-14 (prs1Δprs5Δ) strains  
In addition to interacting with Prs3, Prs1 also interacts with Prs5 (Hernando et al., 
1999). Simultaneous deletion of PRS1 and PRS5 causes cell death (Hernando et al., 
1998). The strain YN97-14 (prs1Δprs5Δ) is kept alive since it contains a plasmid-
borne version of PRS1 (pVT1) which has the URA3 gene as the selective marker. In 
order to determine if any mutant versions of PRS1 could restore viability of YN97-14 
plasmid shuffling experiments (Sikorski and Boeke, 1991) were carried out with 
various mutated versions of PRS1 (Ugbogu et al., 2013). To this end, each of the 
 Chapter 3: Results 
  
 
64 
 
following plasmids (pGBT9, pGBT9-Prs1, pGBT9-prs1(L115T), pGBT9-prs1(H130A), 
pGBT9-prs1(Q133P), pGBT9-prs1(D326A), pGBT9-prs1(H130A/D326A), pGBT9-
prs1(deltaNHR1-1), pGBT9-prs1(∆C600), pGBT9-prs1 (∆Eco RI/Bam HI) and 
pGBT9-prs1(∆Bam HI/Pst I) (cf. Figure 2 in Ugbogu et al. (2013)) was transformed 
individually into YN97-14 by selecting for tryptophan prototrophy since the mutated 
versions of PRS1 are contained in plasmids having TRP1 as the selectable marker. 
Plasmid shuffling experiments exploit the fact that in the presence of 5-fluoroorotic 
acid (5-FOA) a strain can only survive if it is an uracil auxotroph (Boeke et al., 1984). 
The Trp+-transformants were grown in the presence of 5-FOA to determine which of 
the plasmid-borne mutated versions of PRS1 could rescue the synthetic lethality 
caused by the simultaneous deletion of PRS1 and PRS5 (Ugbogu et al., 2013). Only 
five of the plasmids tested maintained the viability of the double deletant strain, viz 
pGBT9-Prs1, pGBT9-prs1(L115T), pGBT9-prs1(Q133P), pGBT9-prs1(D326A) and 
pGBT9-prs1(H130A/D326A) and they are illustrated in Figure 3.6. 
 
 
 
 
 
 
  
 
 
The closed and open symbols indicate the positions of the in vitro-generated point mutations in PRS1. 
NHR1-1, non-homologous region of Prs1 (taken from (Ugbogu et al., 2013)).  
 
 
Prs1 
L115T 
H130A 
Q133P 
D326A 
H130A/D326A 
Figure 3.6:  A schematic representation of in vitro mutated versions of PRS1 
capable of rescuing synthetic lethality 
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3.4.1 Temperature sensitivity of YN97-14 rescued strains   
Yeast cells have no internal temperature regulator, therefore the higher the 
temperature the more damage to the yeast cell, thereby causing rapid decline of cell 
viability (Walker, 1998). Response to mild heat-shock (37-39°C) involves activation 
of specific heat shock proteins that enable the cells to adapt and survive (Ye et al., 
2009, Rikhvanov et al., 2014). Heat shock affects many cellular processes: these 
include transient cell division arrest, build-up of misfolded proteins, uncoupling of 
oxidative phosphorylation, damage and defects of cell wall biosynthesis (Richter et 
al., 2010), thus reducing significantly the rate of protein synthesis by focusing on the 
synthesis of heat shock proteins for the repair or remodelling of the cells and also for 
cell survival (Jarolim et al., 2013).  
The response of YN97-14 [(prs1-L115T)], YN97-14 [(prs1-Q133P)], YN97-14 [(prs1-
D326A)] and YN97-14 [(prs1-H130A/D326A)] to mild heat-shock was examined by 
spotting the cultures on solid media and incubating the plates at 30oC and 37oC.  
Single colonies from each of the above-named strains containing the Rlm1 
expression plasmid were inoculated individually into SC-Ura-Trp and grown o/n at 
30oC with shaking. Serial dilutions of the o/n cultures were spotted onto appropriate 
media (Materials and Methods, section 2.5.1). The plates were incubated for 3 days 
at 30oC and 37oC. Figure 3.7 shows that in all the strains no growth was observed at 
37oC. Interestingly, the growth impairment of the strains at 37oC was corrected if 1 M 
sorbitol was included in the media. However, it was observed that YN97-14 [(prs1-
Q133P)] grew less well than the other strains at either temperature, implying that the 
Q133P mutation may affect Prs1 more severely than the other mutants. 
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Figure 3.7: Temperature sensitivity of YN97-14 rescued strains 
The rescued strains YN97-14 [(prs1-L115T)], YN97-14 [(prs1-Q133P)], YN97-14 [(prs1-D326A)] and 
YN97-14 [(prs1-H130A/D326A)] were grown o/n at 30°C with shaking. OD600 was determined and 
adjusted to 0.5 for each culture. The cultures were serially diluted in sterile distilled H2O. 3 µl of the 
individual dilutions were then spotted onto appropriate selective media (SC-Ura-Trp plates) with and 
without I M sorbitol. The plates were incubated for 3 days at 30°C and 37°C.  
 
3.4.2  Caffeine sensitivity of YN97-14 rescued strains 
S. cerevisiae must have a functional PKC1 to cope with cell wall stresses caused by 
environmental changes and toxic substances to guarantee CWI essential for cell 
viability and survival (Levin, 2005, Fuchs and Mylonakis, 2009, Soriano-Carot et al., 
2012). To gain further insight into possible links between Prs polypeptides and the 
CWI pathway, the ability of the rescued strains to grow in the presence of caffeine 
was tested. Sensitivity to the purine analogue, caffeine, (Hampsey, 1997) is a 
diagnostic phenotype of yeast strains with a compromised CWI pathway  (Mart  n et 
al., 2000, Levin, 2011). Compromised CWI has been observed in strains deleted for 
one of or more of the five PRS genes, in particular, those lacking Prs1/Prs3, one of 
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the minimal functional complexes, required for cell viability (Schneiter et al., 2000, 
Wang et al., 2004). 
The effect of caffeine on the growth of YN97-14 rescued by WT Prs1 or one of the in 
vitro-generated Prs1 point mutations L115T, Q133P, D326A or the double mutation, 
H130A/D326A was tested. After spotting, the plates were incubated for 3 days at 
30oC. As shown in Figure 3.8 each of the rescued strains was sensitive to caffeine. 
YN97-14 [prs1(L115T)], YN97-14 [prs1(D326A)] and YN97-14 [prs1(H130A/D326A)] 
showed a similar growth pattern on 2 mM and 3 mM caffeine as YN97-14 [Prs1]. 
However, YN97-14 [prs1(Q133P)] was more sensitive being unable to grow even at 
the lowest dilution on 3 mM caffeine. As can be seen the inclusion of 1 M sorbitol in 
the media corrected the caffeine sensitivity to the extent that YN97-14 [prs1(Q133P)] 
could grow on 3 mM caffeine. However, the caffeine sensitivity of the strain 
containing the H130A/D326A mutation was more pronounced than in the other 
strains. Exposure of the strains to caffeine and elevated temperature simultaneously 
in the presence of sorbitol prevented growth of YN97-14 [prs1(Q133P)] and 
permitted growth of the other strains only with the undiluted o/n culture. The 
correction of the caffeine sensitivity by 1 M sorbitol is similar to the correction of 
temperature sensitivity illustrated in Figure 3.7. 
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Figure 3.8: Effect of sorbitol on caffeine sensitivity of the rescued YN97-14 strains 
YN97-14 [Prs1], YN97-14 [prs1(L115T)], YN97-14 [prs1(Q133P)], YN97-14 [(prs1(D326A)] and YN97-14 [prs1(H130A/D326A)], each containing the Rlm1 
reporter plasmid [pHPS100-Ura] were grown o/n at 30
o
C with shaking. The OD600 of the o/n cultures were measured and subsequently adjusted to 0.5 
followed by 10-fold serial dilutions (10 
-1 
-10
-3
). 3 µl of the individual dilutions were then spotted onto SC-Ura-Trp with and without caffeine or caffeine in the 
presence of I M sorbitol and incubated at 30°C or 37°C for three days.  
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3.4.3 β-galactosidase activity as a measure of Rlm1 expression in viable 
transformants of YN97-14 (prs1∆prs5∆) 
Since it has been hypothesized that impaired CWI signalling contributes to the 
synthetic lethality of the prs1∆ prs5∆ strain (Ugbogu et al., 2013), it was decided to 
examine the phosphorylation status of Slt2 in these rescued strains. This was done 
indirectly since expression from the Rlm1 reporter plasmids occurs only when Slt2 is 
phosphorylated. Although, as shown in Figure 3.7, the rescued strains are unable to 
grow at 37oC on solid media, it was decided to see how the strains behaved at 37oC 
in liquid media. Rlm1 expression was measured by means of β-galactosidase activity 
after incubation at 30oC and 37oC. The transformed strains were grown o/n and 
diluted into 2x50 ml of the same media to an OD600≈ 0.3. One flask was incubated at 
30oC and the other at 37oC until mid-log phase (OD660 ≈ 1.0) was achieved. Not 
unexpectedly the cultures incubated at 37oC grew slowly but did reach OD660 = 1.0 
after 8 hr. Nevertheless β-galactosidase activity was measured in cultures from both 
temperatures. The data obtained for the 30oC cultures showed variation in Rlm1 
expression. When WT Prs1 is the rescuing plasmid the value is lower than that for 
YN96-68 (prs5∆) (see inset of Figure 3.9), although both are lacking PRS5. For the 
remaining rescuing plasmids only Q133P has reduced Rlm1 expression at 30oC with 
respect to the other strains tested. The Rlm1 expression measured at 37oC should 
be treated with caution since, as shown above, they are incapable of growing at 
37oC in the absence of an osmotic stabilizer (Figure 3.7) and the time taken to reach 
OD600 1.0 was 8 hr. 
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Figure 3.9: Rlm1 expression at 30oC and 37oC as measured by β-galactosidase 
activity in the prs1∆prs5∆ rescued strains 
Rlm1 activation was measured in YN97-14 (prs1∆prs5∆) strains containing the Rlm1 reporter and a 
pGBT9-based plasmid carrying the WT or mutated versions of PRS1 which rescued synthetic lethality 
(Ugbogu et al., 2013). The histogram was obtained by duplicate or triplicate measurements of Rlm1 
expression in three independent transformants for each combination. The data is represented as the 
mean ± s.d., *p<0.05, **p<0.01 (TukeyHSD test), n.s., not statistically significant. The raw data are 
shown in the Appendix, Table 5.1. The inset is taken from Figure 3.12 and shows temperature-
dependent Rlm1 expression in YN96-68 (prs5∆) [pGAD].  
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3.4.4 Phosphorylation status of Slt2 in rescued prs1Δprs5Δ deletant strains 
Previous work on Prs has shown that deletion of NHR1-1 abolished the temperature-
induced Rlm1 expression of Prs1 (Ugbogu et al., 2013). It has been found that the 
NHR1-1 region of PRS1 gene is vital for the Prs1 polypeptide to interact with Slt2 
(Wang et al., 2004, Vavassori et al., 2005a, Vavassori et al., 2005b), suggesting that 
the observed prs1Δ prs5Δ synthetic lethality may be associated with perturbation of 
the CWI pathway (Ugbogu et al., 2013). Therefore, it was decided to check the 
phosphorylation status of Slt2 in the rescued prs1Δprs5Δ deletant strains by Western 
blotting. The Western blot was performed using the same cultures which had been 
used for measuring Rlm1 expression (Figure 3.9). The intensity of the P-Slt2 signal 
in each instance is stronger at 37oC than at 30oC and with the exception of Q133P 
the P-Slt2 signal of the mutants is weaker than that obtained with the strain rescued 
by WT Prs1 (Figure 3.10). The strength of the P-Slt2 signals relative to the 
corresponding Slt2 signal is illustrated in Figure 3.11 and they reflect the modest 
increase in Rlm1 expression following incubation at 37oC.  
 
Figure 3.10: Phosphorylation status of Slt2 in rescued YN97-14 (prs1∆prs5∆) 
strains 
For each strain crude extract equivalent to 15 µg protein per lane was separated on a 4-20% SDS-
PAGE gel, transferred to a PVDF membrane and incubated against P-Slt2 (anti-phospho-
pThr
202
/Tyr
204
)
 
as the primary antibody (sc-16982-R, 1:5000 dilution) for 1 hr followed by incubation 
with goat anti-rabbit IgG-HRP (sc-2004, 1:5000 dilution). The membrane was stripped and re-probed 
to detect Slt2 with the primary antibody against Slt2 for 1 hr (sc-20168, 1:1000 dilution) followed by 
incubation with goat anti-rabbit IgG-HRP (sc-2004, 1:5000 dilution). The relative Slt2 activation was 
quantified by dividing the density of P-Slt2 band by the density of the corresponding Slt2 band. 
Western blots were performed on three biological replicates. 
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Figure 3.11: Quantification of P-Slt2 status in YN97-14 (prs1Δprs5Δ) rescued 
strains 
The detected chemiluminesence signal from the Western blot in Figure 3.10 was quantified using 
ChemiDoc XRS+ imager (cf. Materials and Methods, section 2.12). The relative P-Slt2 level for each 
rescued strain was obtained by dividing the density of P-Slt2 signal by the density of the 
corresponding Slt2 signal. Each value represents the mean ± SEM for three biological replicates. The 
raw data are shown in Appendix, Table 5.2.  
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3.5 Mutation of postulated phosphorylation sites of Prs5 influences 
temperature-induced Rlm1 expression 
Prs5 with a MW of 54 KDa, is the largest polypeptide encoded by any of the five 
PRS genes in S. cerevisiae (Carter et al., 1997, Hernando et al., 1999, Schneiter et 
al., 2000). The reason for this is that it contains two NHRs: NHR5-1 and NHR5-2. 
NHR5-1 consists of 70 aa and is located directly in front of the divalent cation-
binding site whereas NHR5-2 consists of 116 aa and is located at a similar position 
to NHR1-1 of Prs1 (Hernando et al., 1998, Vavassori et al., 2005a). By 
phosphoproteome analysis it was shown that Prs5 is one of the 11 triply 
phosphorylated proteins in yeast (Ficarro et al. (2002)). The three aa residues of 
Prs5 found to be phosphorylated are to be found at the positions S364, S367 and S369 
and are located in the NHR5-2. The aa residues S364, S367 and S369 were converted 
to non-phosphorylatable residues. In addition, other potential phosphorylation sites in 
close proximity to those postulated were also mutated (personal communication, Dr. 
Lilian Schweizer). All mutations were confirmed by sequencing and are documented 
in Table 3.1.  
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Table 3.1: Mutations of the triply phosphorylated aa residues of the Prs5 polypeptide 
The three postulated phosphorylated sites, S364, S367 and S369 and flanking theoretically phosphorylatable residues between aa 355 and 375, of the WT Prs5 
Ficarro et al. (2002) were mutated by in vitro mutagenesis. Specifically, the hydrophilic serine residues at S364, S367 and S369 of the WT Prs5 were replaced by 
alanine (A) residues to generate prs5(479). Prs5(362.2) and prs5(365.1) were created by introducing additional mutations to prs5(479) at the positions 
indicated by the red lettering. The deleted region in prs5(365.5) (indicated by dashes) arose fortuitously during in vitro mutagenesis and the resulting frame-
shift created a truncated Prs5 polypeptide. Single mutations for the postulated phosphorylation sites – S364, S367 and S369 –  were also created. 
Prs5 WT                   
355
A A L E M K K    T
362
     T
363
     Sp364   T365    S          Sp367      T           Sp369      S Q S S N  S375 
 
prs5(479)                     A A L E M K K    T
362
     T
363
     S
364
A  T
365
    S          S
367
A     T          S
369
A      S Q S S N  S
375
 
   
prs5(S364A)                A A L E M K K    T
362
      T
363
    S
364
A   T
365
    S         S
367
       T          S
369
         S Q S S N  S
375
 
prs5(S367A)                A A L E M K K    T
362
      T
363
    S
364
     T
365
    S         S
367
A     T          S
369
         S Q S S N  S
375
 
prs5(S369A)                A A L E M K K    T
362
      T
363
    S
364
     T
365
    S         S
367
       T          S
369
A       S Q S S N  S
375
 
 
 
prs5(362.2)                  A A L E M K K    T
362
A   T
363
A  S
364
A   T
365
A  S         S
367
A    T          S
369
A       S Q S S N  S
375
 
  
prs5(365.1)                  A A L E M K K    T
362          
T
363
   S
364
A    T
365
A S
366
A   S
367
A    T
368
A   S
369
A        S Q S S N  S
375
 
  
prs5(365.5)                  A A L E M K K    T
362          
T
363
     -         -        -           -           -           R             R N  L  L I  R 
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In order to determine what, if any, influence the mutations have on CWI, WT PRS5 
or the plasmid-borne mutated versions thereof listed in Table 3.1 were transformed, 
individually into YN96-68 (prs5∆ [pHPS100-Ura]) and Rlm1 expression was 
measured at 30oC and 37oC. The transformants were streaked out onto appropriate 
media and incubated at 30oC for three days until well-defined colonies had 
developed. A single colony from each transformed strain was inoculated into 10 ml 
SC-Leu-Ura media, incubated o/n with shaking at 30oC and processed for the 
measurement of Rlm1 expression as described in Materials and Methods, section 
2.13. When an intact PRS5 gene is present β-galactosidase activity increases 
approximately 2.5-fold following incubation at 37oC (Figure 3.12). In the absence of 
PRS5 Rlm1 expression at 30oC is virtually identical to that of the WT but the 
increase in expression at 37oC is less than 1.5-fold (vector). Of the four in vitro-
mutated strains only prs5(365.1) showed a reduced Rlm1 expression at 30oC which 
is capable of increasing 1.4-fold following incubation at 37oC. Of the three remaining 
mutations the truncated version of Prs5, prs5(365.5), has an elevated Rlm1 
expression at 30oC which increases approximately 1.4-fold. Both prs5(479) and 
prs5(362.2) have elevated expression at 30oC which in the latter increases only 
minimally following incubation at 37oC. In summary the altered Rlm1 expression in 
the Prs5 mutants tested would suggest that interfering with Prs5 alters signalling 
through the CWI pathway. 
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Figure 3.12: Influence of mutating the postulated phosphorylation sites in Prs5 
on Rlm1 expression at 30oC and 37oC 
In this experiment YN96-68 (prs5∆) transformants containing the Rlm1 reporter plasmid 
(pHPS100-Ura) and individual plasmid-borne mutated versions of Prs5 (cf. Table 3.1) were used to 
evaluate Rlm1 expression following incubation at 30
o
C and 37
o
C. All strains were grown on SC-Leu-
Ura media o/n at 30
o
C before incubation at 30
o
C or 37
o
C in 50 ml of the same culture media until an 
OD660 ≈ 1.0 was obtained. Each value represents the mean ± s.d. for nine measurements for each of 
three independent transformants, *p<0.05, **p<0.01 (TukeyHSD test), n.s., not statistically significant. 
The raw data are shown in Appendix, Table 5.3.  
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3.5.1 Influence of in vitro generated PRS5 mutations on the phosphorylation 
status of Slt2 
In addition to being assayed for Rlm1 expression (cf. Figure 3.12), the cultures 
grown at 30oC and 37oC were used to prepare crude extracts which were subjected 
to Western blotting (Material and Methods, section 2.10) to determine the 
phosphorylation status of Slt2. AS can be seen in Figure 3.13 in the WT PRS5 strain, 
the signal obtained at 30oC for P-Slt2 increased in intensity after incubation at 37oC. 
All other transformants, with the exception of prs5(362.2), showed a temperature-
dependent increase in the phosphorylation status of Slt2. The mutant prs5(362.2) 
was apparently phosphorylated to the same degree at 30oC and 37oC and correlates 
with the non-significant increase in Rlm1 expression at 37oC (Figure 3.12). Signal 
strength was quantified and the data are presented in the Figure 3.14. The β-
galactosidase activity as a measure of Rlm1 expression in the in vitro mutated 
versions of Prs5 correlates with the signal quantification of P-Slt2 relative to the anti-
Slt2 signal with the exception of prs5(479) which had elevated Rlm1 expression at 
30oC. Furthermore, prs5(365.1) has reduced Rlm1 expression at both 30oC and 
37oC which correlates with the reduced P-Slt2 signal.  
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Figure 3.13: Elevated incubation temperature influences the phosphorylation status of Slt2 in PRS5 mutants 
For each strain crude extract equivalent to 15 µg protein per lane was separated on a 4-20% SDS-PAGE gel and transferred to a PVDF membrane. The 
membrane was cut horizontally into two sections: the upper section was probed with antibodies against P-Slt2 (anti-phospho-pThr
202
/Tyr
204
)
 
as primary 
antibody (sc-16982-R, 1:1000 dilution) and anti-goat-rabbit secondary antibody (sc-2004, 1:5000 dilution). Slt2 was detected by stripping and re-probing the 
same membrane with anti-Slt2 primary antibody (sc-20168, 1:1000 dilution) and secondary antibody IgG-HRP (sc-2004, 1:5000 dilution). The lower section of 
the membrane was probed for actin (loading control) using anti-actin goat primary polyclonal IgG (sc-1615, 1:1000 dilution) and donkey anti-goat secondary 
IgG-HRP (sc-2020, 1:10000 dilution). The signals were detected by chemiluminescence. Western blots were performed on three biological replicates. 
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Figure 3.14: Quantification of P-Slt2 in strains carrying the in vitro mutated 
versions of Prs5 
The detected chemiluminescence signals from the Western blots (Figure 3.13) were quantified using 
the ChemiDoc imager. The relative P-Slt2 level was obtained by dividing the density of the P-Slt2 
signasl by the density of the actin signal. Each value represents the mean ± S.E.M. The raw data are 
shown in Appendix, Table 5.4. 
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3.5.2 What is the individual contribution of the three postulated 
phosphorylated serine residues mutated in prs5(479) to Rlm1 
expression following growth at elevated temperature? 
In an attempt to answer this question each of the serine residues at positions 364, 
367 and 369 was mutated individually to alanine (Table 3.1). The mutations were 
confirmed by sequencing and the mutated plasmids were introduced into YN96-68 
(prs5∆ [pHPS100-Ura]) to create the following strains: YN96-68 [pHPS100-
Ura;prs5(S364A)], YN96-68 [pHPS100-Ura;prs5(S367A)] and YN96-68 [pHPS100-
Ura;prs5(S369A)]. Each of the single mutants was capable of increased Rlm1 
expression, approximately two-fold, following incubation at 37oC (Figure 3.15). This 
is in comparison to prs5(479) which has an elevated Rlm1 expression relative to the 
WT at 30oC and increases only 1.25-fold after incubation at 37oC. It can be said that 
none of the individual mutants responded differently from the situation illustrated by 
the two independent transformants YN96-68 [Prs5;pHPS100-Ura] and YN96-68 
[pHPS100-Ura;Prs5] recreating the WT genotype by inverting the order in which the 
plasmids were transformed into YN96-68. Nevertheless, none of the mutants 
displayed the elevated Rlm1 expression measured in prs5(479) at 30oC, implying 
that when all three serine residues are mutated they have an additive effect on 
signalling in the CWI pathway. 
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Figure 3.15: Rlm1 expression of single mutations of Prs5 in comparison with 
Prs5 (WT) and prs5(479) 
In this series of experiments, the YN96-68 transformants containing the Rlm1 reporter plasmid 
(pHPS100-Ura) and plasmid-borne single mutation of phosphorylatable version of Prs5 and two 
independent WT strains created by changing the order in which the two plasmids were transformed 
as indicated by # and § were used to measure Rlm1 expression following incubation at 30
o
C and 
37
o
C. All strains were grown on SC-Leu-Ura media o/n at 30
o
C before incubation at 30
o
C or 37
o
C in 
50 ml of the same culture media until an OD660 ≈ 1.0 was obtained. Data: mean ± s.d. for three 
measurements for two independent transformants; *p<0.05, **p<0.01 (TukeyHSD test). The raw data 
are shown in Appendix, Table 5.5.  
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3.5.3 Phosphorylation status of Slt2 following mutation of S364, S367 and S369 
aa residues of Prs5 
The involvement of the three phosphosites of Prs5 at aa residues S364, S367 and S369 
(Table 3.1) on the phosphorylation status of Slt2 was examined in response to mild 
heat shock at 37oC. This was achieved by inoculating cultures grown at 30oC into 
media pre-warmed to 37oC and is a recognised means of achieving mild heat shock 
(Levin, 2005). The cultures used for Rlm1 expression (cf, Figure 3.14) were 
processed and subjected to Western blotting (Material and Methods, section 2.10). 
Each of the single mutants displayed a pattern of Slt2 phosphorylation comparable to 
that of the WT following incubation at 37oC. This is in contrast to prs5(479) which 
has an elevated Rlm1 expression and a strong P-Slt2 signal at 30oC. No changes in 
the Slt2 or actin signals were observed at either temperature or in response to the 
Prs5 variant present (Figure 3.16). Signal strength was quantified and the data are 
presented in the Figure 3.17. 
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Figure 3.16: Slt2 phosphorylation status of single serine residues, S364, S367 and S369, mutated in prs5(479) 
The cultures used for β-galactosidase activity were processed for Western blotting. The membrane was cut and challenged with the antibodies as described 
in the legend to Figure 3.13. The three signals were detected by chemiluminescence. Western blots were performed on three biological replicates.  
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Figure 3.17: Quantification of P-Slt2 status of single serine residues mutated in 
prs5(479) 
Chemiluminescence signals from the Western blot shown in Figure 3.16 were quantified. The relative 
P-Slt2 level was obtained by dividing the density of the P-Slt2 signal by the density of the 
corresponding actin signal. Two independent WT strains created by changing the order in which the 
two plasmids were transformed are indicated by # as well as §. Each value represents the mean ± 
SEM. WT was transformed in different orientation. The raw data are shown in Appendix, Table 5.6.  
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3.5.4 Evaluation of Fks2 expression in the single mutations S364A, S367A and 
S369A of Prs5 in comparison to Prs5 (WT) and prs5(479) 
FKS1 and FKS2, are a pair of closely related genes that encode alternative subunits 
of the glucan synthase (GS) complex, each capable of supporting GS activity or cell 
viability. Fks2 is responsible for synthesizing 1,3-β-glucan chains, a major structural 
component of the cell wall in S. cerevisiae (Zhao et al., 1998, Sobering et al., 2002).    
The MAPK/Slt2 activation predominantly activates downstream transcription factors, 
which in turn activate the expression of cell wall-related proteins of which Fks2 is one 
(Zhao et al., 1998, de Nobel et al., 2000a). Mild heat shock activates FKS2 
expression via CWI signalling (Jung et al., 2002). Previous work has shown that 
FKS2-lacZ is one of the reliable reporters to examine CWI-induced transcription 
caused by heat shock and other toxic or cell wall-damaging agents, such as Congo 
red, CFW or caffeine (Kim et al., 2008, Levin, 2011). 
Vavassori (2005) has demonstrated that deletion of PRS5 abolishes the 
temperature-dependent increase in Fks2 expression. The influence of the in vitro 
mutations of PRS5 on the expression of FKS2, was investigated as follows: YN96-68 
containing the WT Prs5, the non-phosphorylatable mutants of Prs5 or the vector was 
transformed with the FKS2-lacZ reporter plasmid. β-galactosidase activity was then 
measured at 30oC and 37oC. It is obvious from Figure 3.18 that in the absence of 
PRS5 Fks2 expression is considerably reduced following incubation at 37oC in 
comparison to the WT, although Rlm1 expression is virtually identical to that of the 
two WT strains tested (cf. Figure 3.15). However, the levels of detectable Fks2 
expression for the individual mutants grown at 30oC are similar to those of Prs5 
whereas prs5(479) has elevated Fks2 expression. After mild heat shock at 37oC 
induction of Fks2 expression in the WT and the mutant S369A achieved a 2.5-fold 
increase whereas the mutations at S364A and S367A had similar Fks2 expression as 
prs5(479) under the same conditions, although this mutant had a level of Fks2 
expression at 30oC which is comparable with that of the PRS5 deletant strain after 
heat shock. This result is in agreement with the observations reported for the same 
set of strains tested for Rlm1 expression (Figure 3.15), lending weight to the 
hypothesis that the Prs5 polypeptide plays at least a supporting role in the 
maintenance of CWI. 
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Figure 3.18: Fks2 activity of individual mutations of S364A, S367A and S369A 
of Prs5 in comparison to Prs5 (WT) and prs5(479) 
The YN96-68 transformants were grown o/n in SC-Leu-Ura media and diluted into fresh SC-Leu-Ura 
media with a starting OD600≈ 0.5 before incubating for 3 hr at 30
o
C or 37
o
C. Two independent WT 
strains created by changing the order in which the two plasmids were transformed are indicated by # 
and §, respectively. Each value plotted represents the mean ± s.d. of three measurements each for 
two independent transformants; *p<0.05, **p<0.01, (TukeyHSD test). The raw data are shown in 
Appendix, Table 5.7.  
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3.6 Introduction of Prs5 and in vitro-generated mutations thereof into YN97-
14 rescued strains results in a synthetic growth defect and 
compromised CWI signalling 
The importance of intact PRS1 for the maintenance of CWI and cell viability in S. 
cerevisiae has been documented previously (Ugbogu et al., 2013). Plasmid versions 
of Prs5 [pGAD-Prs5] and mutated versions therof were transformed into YN97-14 
containing pHPS100-Ura and pGBT-Prs1. This series of transformants was 
examined for their ability to grow at 30oC and 37oC and for their Rlm1 expression at 
both temperatures. As illustrated in Figure 3.19 all strains grew at 30oC but growth 
was completely abolished at 37oC unless the media contained 1 M sorbitol.  
 
Figure 3.19: Temperature sensitivity of strains obtained by combining Prs1 
and the in vitro mutations of Prs5 in YN97-14 
YN97-14 containing the Prs1-and the Prs5-plasmids indicated were grown o/n at 30
o
C in SC-Ura-Trp-
Leu and processed for spotting on the same media with or without 1 M sorbitol as described in 
Materials and Methods, section 2.5.1. The plates were incubated at 30
o
C and 37
o
C for three days and 
images were obtained on the third day by the ChemiDoc imager. 
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After spotting Rlm1 expression was tested in four biological replicates of each 
transformant by culturing single colonies from either the sorbitol-free plate incubated 
at 30oC or from the sorbitol-containing plate incubated at 37oC. As shown in Figure 
3.20(a) following incubation at 30oC the plasmid combination Prs1+prs5(365.1) had 
the highest Rlm1 expression followed by the combination Prs1+Prs5 and 
Prs1+prs5(365.5). However, the combination of Prs1 with either prs5(479) or 
prs5(362.2) resulted in Rlm1 expression at a level comparable to the combination 
Prs1+vector. On the other hand, Rlm1 expression in the cultures grown at 37oC, in 
spite of being lower than the expression at 30oC was higher in all combinations of 
Prs1 with Prs5 and the mutated versions thereof than in the combination 
Prs1+vector. This unexpected reduced level of Rlm1 expression following mild heat 
shock may be due to the presence of sorbitol in the culture medium and has been 
encountered previously (Alonso-Monge et al., 2001, Wojda et al., 2003).  
In three of the four remaining rescued strains it was possible to measure Rlm1 
expression following combination of prs1(L115T), prs1(D326A) and 
prs1(H130A/D326A) with Prs5 and in vitro-generated mutations thereof (Figure 
3.20(b)-(c)).The combination of Prs5 WT with each of the Prs1 mutations did not 
result in Rlm1 expression at the level measured for Prs1+Prs5 (cf. Figure 3.20(a)). 
The elevated Rlm1 expression observed for the combination Prs1+prs5(365.1) was 
not observed in any of the combinations tested. When Prs5 was combined with 
prs1(H130A/D326A) Rlm1 expression was virtually abolished at 30oC but increased 
6-fold following incubation at 37oC. The combination of prs1(H130A/D326A) with 
prs5(362.2) had elevated Rlm1 expression at 30oC but the lowest at 37oC of all 
combinations with this double mutant. Even taking into consideration the fact that the 
presence of sorbitol can interfere with CWI it is obvious that the combination of WT 
Prs1 and its various in vitro-generated mutations and WT Prs5 and its various in 
vitro-generated mutations has a profound effect on CWI signalling. 
When prs1(Q133P) was combined with Prs5 and its derivative growth at 30oC was 
reduced at 30oC (cf. Figures 3.19 and 3.21) and was not corrected by the addition of 
sorbitol to the media. In common with the other combinations of Prs1 with Prs5 there 
was no growth at 37oC and inclusion of 1 M sorbitol in the media corrected this 
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growth defect only partially. In spite of repeated attempts it proved impossible to 
measure Rlm1 expression in this context.  
 
Figure 3.20: Influence of Prs5 in vitro mutations on Rlm1 expression in YN97-
14 rescued strains 
Rlm1 expression as a result of combining Prs5 or in vitro mutations thereof with YN97-14 WT Prs1 
(a), YN97-14 prs1(L115T) (b), YN97-14 prs1(D326A) (c) and YN97-14 prs1(H130A/D326A) (d). Four 
biological replicates of each of the tested transformants were cultured at 30
o
C without or at 37
o
C with 
1 M sorbitol and tested for Rlm1 expression. Data: mean ± sd. of three measurements each for two 
independent transformants; *p<0.05, **p<0.01, n.s., not significant (TukeyHSD test). The raw data are 
presented in Appendix, Tables 5.8-5.12. 
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Figure 3.21: Temperature sensitivity of prs1(Q133P) in combination with Prs5 
WT and its derivatives 
Temperature sensitivity of the transformants generated from combination of prs1(Q133P) with WT 
Prs5 or in vitro-generated mutations thereof in YN97-14 was tested. Further details, see legend to 
Figure 3.19. 
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3.7 Detection of His-tagged Prs5 by Western blot analysis 
Recombinant DNA technology enables the modification, expression, identification 
and isolation of proteins of interest from host cells (Young et al., 2012). Isolation and 
purification of proteins have been simplified by fusing tags to create recombinant 
proteins (Terpe, 2003). One of the most commonly used tags is the His-tag which is 
composed of six consecutive histidine residues (6×His). Histidine residues are 
known to interact specifically with divalent metals, such as Ni2+  (Yip et al., 1989). 
This is the basis for the specific interaction which allows the purification of His-
tagged proteins. Ni2+-ions are immobilized on a chromatographic support (Yip et al., 
1989).  The cell lysate is applied under low salt conditions to a column containing the 
immobilized Ni2+-ions and non-specifically bound proteins are eluted under the same 
conditions. The His-tagged protein is then selectively eluted by applying an 
increasing concentration of imidazole. Imidazole mimics histidine and binds to the 
Ni2+-coordination centre of the affinity column and displaces the His-tagged protein. 
Specifically, crude extracts prepared from the strain YN11-01 as described in 
Materials & Methods, section 2.17 were subjected to affinity chromatography. 
Prior to the isolation of His-tagged Prs5  a time course experiment was carried out to 
verify the galactose induction of His-tagged Prs5 encoded by the plasmid, 
pYESDEST52-PRS5-His6X-V5::URA3 (Fasolo et al., 2011). In Figure 3.22, the 
Western blot shows the presence of the band that corresponds to the His-tagged 
Prs5. In addition, since YN11-01 contains an integrated copy of GFP-Prs1 (Schneiter 
et al., 2000) at the PRS1 locus the membrane was also probed with GFP antibodies.   
The signal corresponding to GFP-Prs1 is visible under all growth conditions. The 
lower bands visible in lanes (2)-(5) are the result of the growth in the presence of 
galactose. No band was visible in lane (1) which contains the crude extract of YN11-
01 grown in SC-Ura+2% raffinose for 6 hr. This confirms that YN11-01 contains a 
galactose-inducible His-tagged protein. This protein has a MW of 57 KDa consisting 
of the Prs5 polypeptide with a MW of 53.5 KDa  (http://www.yeastgenome.org/) and 
4 KDa contributed by the C-terminal peptide containing the V5-epitope and the 
polyhistidine tag. 
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Figure 3.22: His-tagged Prs5 and GFP-Prs1 detection by Western blotting 
analysis of crude protein extracts of raffinose-grown and 
galactose-induced cultures of YN11-01   
Lane (1): Crude extract corresponding to 25 ug of protein from YN11-01 grown in SC-Ura+2% 
raffinose for 6 hr. Lanes (2)-(5): Crude extracts corresponding to 25 ug of protein from  YN11-01 
shifted from SC-Ura+2% raffinose to SC-Ura+2% galactose media for 3, 4, 5 and 6 hr, respectively. 
Following electrophoresis on a 4-20% SDS-PAGE gel the products were transferred to a PVDF 
membrane. The membrane was blocked by incubating in 5% non-fat dried milk in TBS-T for 1 hr and 
subsequently incubated with either anti-His antibodies (sc-8036) or anti-GFP antibodies (sc-73556) 
diluted 1:1000 for 1 hr and a 1:5,000 dilution of goat anti-mouse IgG-HRP (sc-2060) for 1 hr. The 
membrane was treated with Bio-Rad detection reagent and exposed to X-ray film for 15 min. There 
was no visible signal in the raffinose-grown YN11-01 crude extract (lane (1)) and there is a visible 
signal after 3 hr of galactose induction which increases slightly with respect to time (lanes (3)-(5)). As 
expected, the strength of the GFP-Prs1 signal remained constant in lanes (1-5). The values are 
expressed as signal strength +/- S.D. The experiment was done on three biological replicates. The 
raw data are shown in Appendix 5.12. 
 
 
3.7.1 Partial purification of His-tagged Prs5 proteins 
The crude extract from the 6 hr galactose-induced YN11-01 culture (Figure 3.22) 
was applied to a (Ni2+)6 fast flow Sepharose
TM column (1 ml HisTrap FF, GE 
Healthcare) connected to the ÄKTA Avant 250 as described in Materials and 
Methods, section  2.16.1. The elution profile of the His-tagged Prs5 protein is shown 
in Figure 3. 23. Fractions corresponding to the protein peak eluting with 200 mM 
imidazole were collected and subjected to Western blotting. The Western blot in 
Figure 3.24 shows that both the crude extract and the purified sample contain a 
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distinct band corresponding to a protein with an apparent MW of 57 KDa. The 
relative intensity of the signals obtained in the crude and affinity-purified extracts is 
consistent with a purification factor of at least 5-fold since the amount of protein 
loaded in lane (2) was 20% of that loaded in lane (1).  
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His-tagged Prs5 was isolated from YN11-01 galactose-induced cells using ÄKTA Avant 250 as described in Materials and Methods, section 2.16.1. The right 
hand y-axis shows the concentration of imidazole in the step gradient used for elution. Crude extract corresponding to 10 mg/ml protein was supplied to the 
column at a flow rate of 1 ml/min. Once the A280nm absorption had reached a minimum, the elution of the His-tagged Prs5 protein was initiated by increasing 
the concentration of imidazole from zero to 500 mM (green trace). Fractions containing the protein peak (Volume 40-44 (ml)) eluting at 200 mM imidazole 
were collected and subjected to Western blotting. 
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Figure 3.23: Purification profile of His-tagged Prs5 obtained from a 6 hr galactose-induced extract of YN11-01 
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Lane (1): 25 µg crude extract of galactose-induced YN11-01 culture for 6 hr. Lane (2): 5 µg of the 
combined fractions eluted from the Ni
2+
-column with 200 mM imidazole as shown in Figure 3.23) were 
separated on a 4-20 % SDS-PAGE and transferred to a PVDF membrane. After transfer and blocking, 
the membrane was treated as described in the legend to Figure 3.22.  
 
 
 
3.7.2 Mass spectrometry (MS) analysis of His-tagged Prs5 
MS analysis was carried out on material obtained from a His SpinTrapTM column. 
The reason for using His SpinTrap technology was to obtain a more concentrated 
protein suspension by reducing the elution volume to 300 µl rather than the 10-fold 
larger elution volume obtained with the ÄKTA purifier Avant 250, thereby allowing the 
visualization of protein bands in a stained gel. A further reason was to reduce the 
purification time. Using the His SpinTrap column takes approximately 10 min 
whereas the automated ÄKTA purification requires at least 1 hr. 10 mg/ml crude 
extract of the YN11-01 [prs5Δ::kanMX4-loxP [pYES-DEST52-PRS5-His6X-
V5::URA3]] prepared as described in Materials and Methods, section 2.15, was 
applied to a 1 ml His SpinTrapTM column, after which the column was washed and 
protein eluted with either 200 mM or 300 mM imidazole-containing buffer (Materials 
and Methods, section 2.16.2). 25 µg of the crude extract and 2.5 µg of the eluted 
fractions were separated on 4-20% SDS-PAGE and subsequently stained with 
Coomassie Blue R250 (Materials & Methods, section 2.9.3), followed by Western 
blotting. Comparison of the stained gel and the corresponding Western blot (Figures 
3.25 (a) and (b)) revealed that the His-tagged Prs5 protein was detectable in the 
crude extract (lane (1)), in the flow through (lane (2)) and in the eluted fractions 
(lanes (5)-(7)). No bands corresponding to His-tagged Prs5 were detectable in lanes 
Figure 3.24: Western blot analysis of YN11-01 crude extract of YN11-01 and 
the peak fractions eluted with 200 mM imidazole 
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(3)-(4). The strength of the signal of the purified samples eluted with 200 mM or 300 
mM imidazole was 10 times stronger than that of the crude extract (cf. lanes (1)-(2) 
and (6)-(7)). The amount of protein applied to lanes (6) and (7) was only 1/10th of 
that applied to lane (1). Taking into consideration the relative signal strengths this is 
consistent with an approximately 100-fold increase in the concentration of His-
tagged Prs5 following His SpinTrap purification.  
 
Interestingly, distinct bands in lanes (4) and (5) of the stained gel (Figure 3.25 (a)) 
did not cross-react with the His-tag antibody, but may represent polypeptides 
associated with Prs5. In order to identify these polypeptides the bands 
corresponding to Prs5 in lane (6) and the two non-cross-reacting bands with an 
apparent MW of 42,000 and 36,000 in lane (4) and (5) were excised from the gel and 
analysed by MS/MS after in-gel trypsin digestion. The MALDI TOF MS analysis was 
carried out by Dr. Catherine Botting and her colleagues at the BMS Mass 
Spectrometry and Proteomics Facility, University of St Andrews. The peptide 
fingerprints detected by the MASCOT search engine (https://bsrcmascot.st-
andrews.ac.uk/mascot/x-cgi/ms-review.exe) were used to interrogate the NCBI 
(http://www.ncbi.nlm.nih.gov/pubmed) and the Saccharomyces Genome Database 
(SGD, http://www.yeastgenome.org) databases. Matches were obtained for Prs5 
with the gel slice from lane (6). Peptides recovered matched 68% of the S. 
cerevisiae (S288c) Prs5 polypeptide. The MS/MS spectrum illustrated in Figure 3.26 
corresponds to aa residues 445-456 of Prs5 with the sequence LIISNTVPQDR 
(Dujon et al., 1997) and a monoisotopic mass (Mr), of 1254.7. 
 
The best matches for the lower (lane (4)) and upper (lane (5)) bands corresponded 
to GAPDH (36 KDa) and elongation factor 1-α (TDH2) (42 KDa), respectively (data 
not shown). 
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Figure 3.25: SDS-PAGE and Western blot analysis of His-tagged Prs5 
25 µg crude extract of YN11-01 and 2.5 µg partially purified His-tagged Prs5 (Materials and Methods 
section 2.16.2) were separated on a 4-20% SDS-PAGE and stained with Coomassie Brilliant Blue 
R250 (a) and subjected to Western blotting (b). The membrane was blocked by incubating in 5% non-
fat dried milk in TBS-T for 1 hr and subsequent incubation with anti-His antibodies (sc-8036) diluted 
1:1000 for 1 hr and a 1:5,000 dilution of goat anti-mouse IgG-HRP (sc-2060) for 1 hr. The membrane 
was treated with Bio-Rad detection reagent and and images obtained using Chemdoc imager. 
Lane M: Marker (PageRuler
TM
 prestained protein ladder, Bio-Rad); 
Lane (1): Crude extract  
Lane (2): Flow through 
Lanes (3)-(4)): Washes with binding buffer containing 20 mM and 50 mM imidazole, respectively 
Lanes (5)-(7): Elution with 100 mM, 200 mM and 300 mM imidazole, respectively. 
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Figure 3.26: CID spectrum of the Prs5 peptide fragment, 117ENYTFESHPGTPVSSSLMTQRPGAESSLK145 (gi: 6324511)
The eluted His-tagged Prs5 was subjected to SDS-PAGE. After staining and Western blotting the band highlighted in Figure 3.25 (a), lane (6) was subjected 
to MS/MS fragmentation after in-gel trypsin digestion. The b-series ion mass is the charge retained on the N-terminal fragment), the y-series ion mass is the 
charge retained on the C-terminal fragment resulting from the breakage of the C-N bond and the y*-series ion mass are products of further fragmentation of 
the y-series. The calculated monoisotopic mass of the peptide is 3136.4771.  
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To further investigate if His-tagged Prs5 co-purifies with other proteins, in addition to 
YN11-01 (prs5Δ::kanMX4-loxP) [pYES-DEST52-PRS5-His6X-V5::URA3]], YN97-91 
(prs2∆ prs4∆ prs5∆::kanMX4-loxP) [pYES-DEST52-PRS5-His6X-V5::URA3] which 
expresses only the Prs1 and Prs3 polypeptides and His-tagged Prs5, were purified 
on His SpinTrap columns. The purified extracts were subjected to SDS-PAGE and a 
section of the gel containing material with a MW in the range of 30-100 KDa was 
excised for each extract (data not shown). Prior to MS/MS analysis on ESI-QUAD-
TOF the prominent band from each extract was excised and analysed separately, 
otherwise it would have dominated the spectrum completely. Using the Mascot 
software and interrogating the NCBI S. cerevisiae database 29 proteins including 
Prs5 and Prs3 were identified in YN11-01. The same search criteria identified 29 
proteins in the prominent band of YN97-91, however, only Prs5, but not Prs3, was 
found.  Analysis of the remainder of the gel slices identified 275 hits for YN11-01 and 
254 for YN97-91 of which 92 were common to both strains. In the YN11-01 sample, 
in addition to Prs3 and Prs5, Prs1 was also identified. The Prs1 peptide identified is 
located in the NHR1-1 region of the protein, thus providing corroborative evidence 
that NHR1-1 is an integral part of the mature Prs1 protein (Figure 3.27). 
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Figure 3.27: CID spectrum of the Prs1 peptide, 307EQLITLVGNVR317 (gi: 6322667) 
A gel ‘chunk’ was digested with trypsin and subjected to MS/MS fragmentation. The NCBI Yeast Database was interrogated by the fragmentation fragments 
and the Prs1 peptide (gi: 6322667) identified which together with four others identified corresponded to a 17% coverage of the Prs1 polypeptide. The b-, y- 
and y*--series ion masses of the peptide are illustrated. The calculated mass of the peptide is 1240.7139. The peptide coincides with the C-terminal junction 
of NHR1-1. 
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The proteins listed in Table 3.2 are a selection of those identified by MS/MS. Prs5, 
elongation factor 1α and TDH2 (GAPDH isozyme 2) identified in the first experiment 
were again identified in the second experiment in addition to other proteins. In the 
second experiment Prs1, Prs3, Prs5, Rho1 and other associated proteins were 
identified for YN11-01. With the exception of Pet9, Rpt4, Prs1, Sfh1, Zuo1 and Rho1 
the same sets of proteins were identified for YN97-91 as shown in Table 3.2. Many 
of the identified proteins are involved in protein synthesis, transcription and heat 
shock response.  
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Table 3.2: Proteins and peptides identified by ESI-MS/MS analysis of YN11-01 and YN97-91 
Protein  Peptide sequence Known function aa location MW 
(KDa) 
YN11-01 YN97-91 
  
Prs5 
 
K.LIISNTVPQDR.T 
 
 
 
445-457 
 
54 
 
+ 
 
+ 
Prs3 
Prs1 
R.ITAIIPNFPYAR.Q 
R.EQLITLVGNVR.G 
PRPP synthesis, histidine & tryptophan 
 
87-100 
306-318 
35 
47 
+ 
+ 
+ 
- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hsp26 R.LLGEGGLR.G Heat shock protein 23-32 24 + + 
Gal1 R.DYLTTSPVR.F Galactose metabolism 375-385 59 + + 
RPL17B K.YLDQVLDHQR.A Protein synthesis 46-57 21 + + 
Vma2  K.ILDEFYDR.A Contains nucleotide binding sites 479-488 57 + + 
Pet9 K.SDGVAGLYR.G Major ADP/ATP translocator 182-192 35 + - 
Mir1 K.FLVFER.A Regulation of calcium-mediated signaling 187-194 33 + + 
Rpt4  R.ASTPMFLLSR.K H3 methylation 343-354 65 + - 
Ser1 K.DLINFNDIGLGIGEISHR.S Required for serine and glycine biosynthesis 28-47 44 + + 
G4p1 K.EQSAQAAQWESVLK.S tRNA aminoacylation 22-37 42 + + 
Yck2 R.GQLPWQGLK.A morphogenesis and glucose sensing 277-287 62 + + 
Pho88 K.APSLFGGMGQTGPK Inorganic phosphate transportation 154-168 21 + + 
Sfh1 R.FATSIVQDLGLTR.E Essential for viability. 309-323 49 + - 
Vma13  K.ATQAIIGYTFK Coupling ATP hydrolysis to proton translocation 288-299 55 + + 
Bmh1 K.ISDDILSVLDSHLIPSATTGESK.V Regulation of exocytosis & MAPK signalling 74-98 30 + + 
Hog1  K.ICDFGLAR.I Regulates stress responses & morphogenesis  152-161 47 + + 
Zuo1 K.TIVDSGKLPSSLLSYFV A member of HSP70 family  416-433 49 + - 
Rho1  R.NDPQTIEQLR.Q Cell wall synthesis & regulates Pkc1 127-138 24 + - 
Mkt1 R.SNTESVLLQR.S Forms cytoplasmic foci upon DNA replication 
stress  
120-131 95 - + 
TDH2 (GAPDH isozyme 2) M.VRVAINGFGR.I Involves in glycolysis & gluconeogenesis 1-12 36 + + 
The list of proteins shown is a selection of the proteins identified in the most prominent band in the gel chunk for MS analysis: aa-amino acid; + detected; - not detected; MW, 
molecular weight. Protein abbreviations and functions were taken from Saccharomyces Genome Database (SGD, http://www.yeastgenome.org). 
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4 Discussion 
One means of gaining insight into the machinery of a cell is to isolate the individual 
components thereof. If the isolation of the individual components is carried out under 
non-denaturing conditions it may be possible to pull out other molecules associated 
with the component being investigated. By exploiting the advantages of protein 
tagging (Lichty et al., 2005), a technique which permits the attachment of a specific 
label to a selected protein, it is possible to gain information about interacting partners 
of the tagged protein within a complex. This provides information on whether or not 
different centres of metabolism are associated with each other in the living cell and if 
so, do specific conditions have to prevail. The associations identified may provide an 
explanation of the unexpected consequences observed when an alteration in the 
cell’s primary metabolism affects an apparently unrelated cell component by 
revealing hitherto undiscovered links in cellular metabolism. 
 
Data obtained can be used to create a map of how different nodes of metabolism 
interact with each other in the cell. It would also be possible to define both spatial 
and temporal interactions between metabolic nodes. Temporal interactions are likely 
to take place at different times during the cell cycle and/or possibly as a response to 
perturbations in the cell’s metabolism whereas spatial interactions ensure the 
smooth running of the cell’s metabolism. The perturbation investigated in this study 
exists in the different yeast strains created which lack one or more of the component 
polypeptides of the Prs enzyme. Information gained on the connectivity of apparently 
unrelated metabolic nodes will help to confirm known metabolic connectivity and has 
the potential to identify hitherto unknown interactions.  
 
Extensive genetic studies have shown that S. cerevisiae cells are viable if they 
contain at least one of the following three minimal functional units – Prs1/Prs3, 
Prs2/Prs5 or Prs4/Prs5 (Hernando et al., 1999). Interestingly, Prs1 and Prs5 
polypeptides contain insertions, termed non-homologous regions (NHRs), because 
at the time of their discovery the NHRs shared no similarity to any known sequences 
available in the databases. In the meantime sequence similarity of 77% has been 
found for Prs1 polypeptides of S. cerevisiae and A. gossypii (Ashbya Genome 
Database, AER083c). The sequence similarity is maintained in the N-terminal portion 
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of NHR1-1 for both species but drops off in the region of the BamHI restriction site 
located centrally in the NHR1-1 of S. cerevisiae. Interestingly, sequences upstream 
of the BamHI restriction site seem to be of importance for the connection of Prs1 and 
Mpk1/Slt2 in S. cerevisiae ((Ugbogu et al., 2013), Figure 5). Overall there is 
approximately 60% sequence identity in the PRS5 genes from S. cerevisiae 
(YOL061w) and A. gossypii (ADR314c). However, there is a loss of sequence 
similarity at the locations of NHR5-1 and NHR5-2. Interestingly, one of the three 
postulated phosphosites of NHR5-2, S367, is conserved in both species. The 
locations of NHR1-1 and NHR5-2 mean that the Mg2+/ATP- and the PRPP-binding 
sites in S. cerevisiae Prs1 and Prs5 are more widely separated than in Prs2, Prs3 or 
Prs4. This could well be an explanation for the requirement of heterodimers as the 
minimal functional unit and correlates with the finding that it proved impossible to 
delete more than three of the five PRS genes and maintain viability (Hernando et al., 
1999). Given the importance of Prs it is not surprising that mutations in any of the 
three human PRPS genes, two of which are X-linked and the third is located on 
chromosome 7 (Becker and Ahmed, 2000), have a serious impact on human 
metabolism. For instance, superactivity of Prs is associated with gouty arthritis 
whereas reduced Prs activity is associated with human neuropathies, such as Arts 
syndrome (de Brouwer et al., 2007) and Charcot-Marie-Tooth (CMTX5) disease 
(Synofzik et al., 2014). By means of in vitro mutagenesis we have introduced 
mutations into the PRS1 gene of S. cerevisiae so that it contained either the 
mutation corresponding to Arts syndrome or CMTX5. Other mutations created in 
PRS1 altered the Mg2+/ATP- and/or the PRPP-binding sites. These mutated versions 
of PRS1 have been used to investigate synthetic lethality caused by simultaneous 
deletion of the PRS1 and PRS5 ORFs. Synthetic lethality of PRS null mutations is 
also encountered when the PRS3 and PRS5 ORFs are deleted simultaneously and 
in the combinations prs1∆prs2∆prs4∆ and prs2∆prs3∆prs4∆ (Hernando et al., 1999). 
The synthetic lethality observed for the null mutations of the PRS genes is consistent 
with the hypothesis that these genes act in parallel pathways– metabolism and CWI– 
as represented by the two interacting sub-complexes, Prs1/Pr3 and Prs2/Prs4/Prs5 
(Tucker and Fields, 2003, Ye et al., 2005, Ooi et al., 2006). All synthetic lethal 
interactions of PRS deletions encountered disturb both sub-complexes. To a certain 
extent these two parallel pathways are compensatory; if PRS1 and PRS3 are 
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deleted the strain is temperature-sensitive and grows more slowly (Wang et al., 
2004) whereas deletion of PRS2 PRS4 and PRS5 does not affect doubling time but 
has a significant impact on the enzyme activity, reducing it to 20% of that of the WT 
which is still sufficient to maintain viability.  
 
The published data by (Ugbogu et al., 2013), obtained during the course of this PhD 
point to the requirement of NHR1-1 of Prs1 for the rescue of synthetic lethality but 
rules out the necessity of the PRPP-binding site at D326 of Prs1. Previously 
published data (Wang et al., 2004) has shown that Prs1 interacts with Slt2/Mpk1, the 
MAPK of the CWI pathway, only when NHR1-1 is present. This is a strong argument 
for the synthetic lethality of a prs1∆prs5∆ strain being the result of a break-down of 
CWI in combination with impaired Prs activity. The interaction of Prs1 with the CWI 
pathway provides physical evidence for the phenotypes – caffeine sensitivity, 
Calcofluor White resistance and release of alkaline phosphatase – all of which are 
associated with PRS1 deletant strains and diagnostic of impaired CWI signalling 
(Schneiter et al., 2000). Interestingly, when the Mg2+/ATP-binding site, H130, is 
mutated there is no rescue but simultaneous mutation of H130 and D326 allows a 
certain degree of rescue. Both the Charcot-Marie-Tooth mutation at L115 and the 
Arts syndrome mutation at Q133 in S. cerevisiae PRS1 are capable of rescuing 
synthetic lethality (Ugbogu et al., 2013).  
In spite of their ability to rescue synthetic lethality it has been shown that in a prs1∆ 
background each of the in vitro-generated PRS1 mutations influenced the 
temperature-dependent expression of Rlm1, a transcription factor belonging to the 
MADS box family (Watanabe et al., 1997) and an endpoint of the CWI pathway, 
following mild heat shock. Each of the mutants caused an increase in Rlm1 
expression at 30°C, albeit not to the extent of a total PRS1 deletion (Ugbogu et al., 
2013). 
Investigation of Rlm1 expression in the rescued strains (Figure 3.9) proved 
interesting and raised further questions. In order to measure Rlm1 expression it is 
necessary to introduce a second plasmid, one of the pHPS100 series of Rlm1 
reporter plasmids (Kirchrath et al., 2000), in this case pHPS100-Leu, into the 
rescued strains.  It would be reasonable to expect that the strain YN97-14 
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(prs1∆prs5∆) rescued with PRS1 would show the same temperature-dependent 
Rlm1 response as a prs5∆ strain. At first glance this is the case. However, closer 
inspection revealed that the rescued strain, in spite of a modest temperature-
dependent increase in Rlm1 expression, had less than 1/3rd of the Rlm1 
transcriptional readout of a prs5∆ strain (Figure 3.9, inset). The only significant 
temperature response was observed in the strains rescued with Q133P or 
H130A/D326A. However, the basal expression of Rlm1 in the strain containing 
Q133P was reduced with respect to the other strains. If there was no 
interdependence of Prs1 and Prs5 the temperature-dependent Rlm1 response 
should have been comparable with that obtained when the same plasmid constructs 
were tested in a prs1∆ strain. When PRS5 is present Q133P increased three-fold, 
D326A and H130A/D326A both increased four-fold whereas L115T increased 10-fold 
(Ugbogu et al., 2013). When PRS5 is absent, it was possible to measure Rlm1 
expression in liquid culture after a heat shock over a period of 2-3 doubling times 
(Figure 3.9). However, none of the rescued strains survived incubation at 37°C when 
grown on plates unless the media contained 1 M sorbitol (Figures 3.7). This is a 
clear indication that the rescued strains have impaired CWI although each of the 
mutated Prs1-plasmids which rescued synthetic lethality contains an intact NHR1-1 
(Figure 1.2) and there is a modest increase in Phospho-Slt2 following exposure to 
mild heat shock in liquid culture over an extended period of time – up to 8 hr (Figure 
3.10).  
One outstanding question concerns the temperature sensitivity of the strains rescued 
with PRS1 and in vitro mutants thereof in pGBT9 vectors. This is in contrast to the 
original YN97-14 strain which contains pVT1 (Hernando et al., 1999). Not only in 
pGAD-based plasmids but also in pGBT9-based plasmids is the expression from the 
ADH1 promoter constitutive, but low (Bartel et al., 1993). A possible explanation is 
that the constitutive ADH1 promoter in the pGBT9 plasmid backbone has a low level 
of expression resulting in PRS1 expression at a level capable of maintaining viability 
at 30oC but is insufficient to cope with temperature stress. 
 
Rescue with Q133P resulted in a lower Rlm1 expression than in any of the other 
rescued strains. The Q133P mutation is located 60 aa residues upstream of NHR1-1 
and three aa residues C-terminal to the cation-binding site. Theoretically, the 
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exchange of P (proline) for Q (glutamine) results in a disturbance of an α-helical 
section of B. subtilis  Prs and hPRPS1, both of which have been crystallized (Eriksen 
et al., 2000, Li et al., 2007) and is termed “helix breakage”. The sequence of this 
region is conserved in the S. cerevisiae PRS1 gene and it is therefore a reasonable 
assumption that the Q133P mutation alters the structure of Prs1. When tested for 
their caffeine sensitivity the rescued strain containing Q133P was more sensitive 
than the others (Figure 3.8). The addition of 1 M sorbitol in the presence of caffeine 
did relieve the caffeine sensitivity of Q133P but to a lesser extent than that of the 
other strains at 30°C. The combined stresses of caffeine and mild heat shock were 
not counteracted in the presence of 1 M sorbitol to the same degree in Q133P as in 
the other rescued strains. These observations are of interest because the rescued 
strain (YN97-14 (prs1∆prs5∆ [prs1(Q133P)]) is more sensitive to caffeine with growth 
being inhibited at 3 mM whereas YN96-65 (prs1∆ [prs1(Q133P)]) (YN96-65) is 
capable of growth in the presence of 4 mM caffeine (Figures 3.8 and ((Ugbogu et al., 
2013), Figure 4). Furthermore, the increased caffeine sensitivity of the rescued 
strains would suggest that the absence of PRS5 has a negative impact on the 
maintenance of CWI.  
Rlm1 expression is dependent on Slt2 phosphorylation (Watanabe et al., 1997). 
However, when the degree of Slt2 phosphorylation was examined by Western 
blotting the reduced expression of Rlm1 in Q133P at 30°C was not associated with a 
reduced phosphorylation level of Slt2 (cf. Figures 3.9 and 3.10). Surprisingly, the 
strength of the P-Slt2 signal in the Western blot varied across the strains tested with 
a temperature-dependent increase being most obvious in L115T, D326A and 
H130A/D326A. However, there was little difference in the relative P-Slt2 signal 
between all five strains at either 30°C or 37°C (Figure 3.11). Astonishingly, there was 
apparent variation in the strength of the Slt2 signal in response to mild heat shock, 
most notably in L115T and D326A. Such a temperature-dependent increase in Slt2 
has been reported previously for an HA-tagged version of Slt2 (Hahn and Thiele, 
2002), although it is generally accepted that Slt2 expression is not temperature-
dependent (Kamada et al., 1995).  
There is cumulative evidence that Prs5 contributes to CWI maintenance, possibly via 
Rlm1 expression.  When CWI is examined in YN96-68 (prs5∆) using the WT and the 
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collection of plasmids (Table 3.1) carrying in vitro-generated mutations of the aa 
residues of Prs5 postulated to be phosphorylated and located in the NHR5-2 region 
there were obvious plasmid-dependent differences in Rlm1 expression (Figure 3.12). 
It is stated in the literature (Ficarro et al., 2002) that of 216 phosphopeptides 
investigated only 11 were triply phosphorylated, one of which is Prs5. The three 
potentially phosphorylatable residues of Prs5 at positions S364, S367 and S369 were 
simultaneously mutated in the plasmid prs5(479). When this plasmid was introduced 
into YN96-68 (prs5∆) Rlm1 expression was increased at 30°C to approximately the 
same level as Rlm1 expression in the prs5∆ strain at 37°C implying that one or more 
of these three phosphosites may play a supporting role in the maintenance of CWI 
via Rlm1 expression. Additional mutations in the neighbouring phosphorylatable aa 
residues also influenced Rlm1 expression, albeit to different extents: mutation of 
residues N-terminal to those in prs5(479) (plasmid prs5(362.2)) caused a further 
increase in Rlm1 expression at 30°C whereas mutation of residues C-terminal to 
those in prs5(479) (plasmid prs5(365.1)) caused a reduction in Rlm1 expression at 
both 30°C and 37°C. Rlm1 expression was elevated at 37°C in the presence of all 
mutated Prs5 plasmids but never to the extent measured when Prs5 WT was 
present. The importance of this region for maintaining CWI is also demonstrated by 
elevated Rlm1 expression at 30°C in the presence of the truncated version of Prs5 
(plasmid prs5(365.5)) which arose spontaneously during in vitro mutagenesis and 
contains a deletion of all three phosphosites and terminates  prematurely 19 aa 
residues beyond them (Table 3.1).  
The importance of Prs1 in the maintenance of CWI of S. cerevisiae has been 
previously reported (Ugbogu et al., 2013) and further investigated here. With the 
intention of re-creating the WT scenario the YN97-14 strains rescued from synthetic 
lethality by Prs1 or mutated versions thereof were transformed with Prs5 (WT) and 
its in vitro-mutated versions. However, the inclusion of the additional plasmid, even 
one containing WT Prs5, failed to correct the temperature sensitivity of the original 
rescued strains. This temperature sensitivity is associated with impaired CWI since 
as shown in Figure 3.19 when Prs1 WT is combined with Prs5 WT, prs5(479), 
prs5(362.2), prs5(365.1) or prs5(365.5), it is possible to rescue the temperature-
sensitive phenotype only by the inclusion of 1 M sorbitol in the media. When Rlm1 
expression was measured only the rescued strains containing Prs5 (WT) or 
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prs5(365.1) (Figure 3.20 (a)) were capable of expressing Rlm1 at 30°C at a level 
comparable with that of a WT strain. In the rescued strains containing prs1(L115T) 
together with Prs5 WT or its mutants no combination had a WT level of Rlm1 
expression. In fact, Rlm1 expression remained at the level measured in the original 
rescued strain with the exception of the combination of prs1(L115T) and the 
truncated version of Prs5 (prs5(365.5)) which achieved a two-fold increase in Rlm1 
expression at 37°C  (Figure 3.20(b)). On the other hand, mutation of the the PRPP-
binding site of Prs1, D326A in combination with Prs5 (WT) and prs5(479) led to a 
1.5-fold increase of Rlm1 expression at the elevated temperature (Figure 3.20(c)). 
However, of all the strains created with H130A/D326A in combination with Prs5 (WT) 
and in vitro mutations thereof only in the presence of Prs5 (WT) was an increase 
measured in Rlm1 expression at 37oC (Figure 3.20(d)) which is close to that reported 
for H130A/D326A in a PRS1 deletant strain ((Ugbogu et al., 2013), Figure 6). 
Surprisingly, prs5(365.2) in this context results in a four-fold increase in Rlm1 
expression at 30°C while at 37°C it is almost completely abolished.   
On combining the helix breaker mutation prs1(Q133P) with Prs5 WT and in vitro 
mutations thereof, it was obvious from the temperature sensitivity test that growth 
was severely impaired at both temperatures and furthermore, the temperature-
sensitive phenotype was not corrected by the inclusion of 1 M sorbitol in the media 
(Figure 3.21). It proved impossible to measure Rlm1 expression even after repeated 
attempts. This is not surprising since Q133P was the one mutant which was least 
successful in rescuing the synthetic lethality of YN97-14 (Figure 3.9) ((Ugbogu et al., 
2013), Figure 3(a)). The inability of all the strains tested to grow at elevated 
temperature is a strong indication that alteration in either PRS1 or PRS5 has a 
significant effect on S. cerevisiae viability and the CWI pathway. It is therefore 
concluded that in addition to providing PRPP to the cell, two of the five Prs 
polypeptides, Prs1 and Prs5, have evolved in such a way that they are required for 
maintenance of CWI.  
Mutation of the three phosphosites individually (Figure 3.15) and examination of their 
influence on Rlm1 expression at 30°C and 37°C, revealed that only when all three 
residues were mutated simultaneously was there a temperature-dependent effect on 
Rlm1 expression. However, in each of the three individual mutations the level of 
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Rlm1 expression was lower at 30°C than in either the WT or prs5(479). Western blot 
analysis of the strains carrying plasmid-borne versions of  the in vitro mutations of 
Prs5 tested for Rlm1 expression was performed to examine the effect of mild heat 
shock on the phosphorylation status of Slt2 (Figures 3.13 and 3.16). Interestingly, 
when the intensity of the protein bands was quantified, the same fold effect was 
observed for all the strains except for the strain carrying prs5(362.2) which had the 
highest degree of phosphorylation at 30°C and increases slightly at 37°C (Figure 
3.14). The elevated P-Slt2 signal at 30°C is in agreement with the elevated Rlm1 
expression of the strain at the same temperature (Figure 3.12). The phosphorylation 
status of Slt2 in the strains carrying the individually mutated postulated phosphosites 
at aa residues 364, 367 and 369 is virtually the same as in the WT at 30°C and 37°C 
but lower than in prs5(479). Of the three individual mutants the P-Slt2 signal reaches 
the highest level in prs5(S369A) following incubation at 37°C (Figures 3.16 and 
3.17).   
To extend the investigation of Prs5’s role in CWI we tested the influence of the 
mutations on Fks2 expression, which is a second endpoint of the CWI pathway 
(Zhao et al., 1998, de Nobel et al., 2000a) and provides a measure of cell wall 
damage (Jung and Levin, 1999, de Nobel et al., 2000a, Truman et al., 2009, Kim and 
Levin, 2010). It was previously shown (Vavassori, 2005, Wang, 2005) that in the 
absence of PRS5, in comparison to the WT, Fks2 expression was not increased 
following mild heat shock. When the combined and individual versions of the three 
phosphorylation sites, 364, 367 and 369, were tested for Fks2 expression following 
heat shock, none of the individual mutants responded differently to heat shock from 
the WT. However, simultaneous mutation of the three residues in question resulted 
in increased Fks2 expression at 30°C and a reduction in the increase of the 
expression at 37°C (Figure 3.18).  
In summary it can be said that mutation of the three postulated phosphosites in Prs5 
and the neighbouring region influences both Rlm1 and Fks2 transcriptional readouts 
as well as Slt2 phosphorylation. However, it cannot be said whether the influence of 
Fks2 is mediated directly via the influence of Mpk1/Slt2 on SBF or via Rlm1 acting 
on Mlp1 which in turn influences Swi4/Swi6 or a combination of both (Figure. 7) (Kim 
et al., 2008, Levin, 2011).  
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Mpk1/Slt2 phosphorylates Rlm1 under cell wall stress. Among the genes activated is MLP1, an 
orthologue of MPK1. Mlp1 is phosphorylated at T192 by Mkk1/2 and is an alternative activator for the 
Swi4/Swi6 transcription factor stimulating FKS2 expression (modified after Levin, 2011). 
 
An interesting connection between Fks2 and Prs1 occurs during transcription 
initiation of the FKS2 gene. FKS2 is one of the genes transcribed by the Paf1 
complex (Chang et al., 1999, Truman et al., 2009, Kim and Levin, 2011). It has been 
demonstrated recently that there is an interaction between Mpk1/Swi4/Swi6 and the 
Paf1 complex at the promoter of FKS2. When the FKS2 promoter is occupied by 
these two complexes, Mpk1/Slt2 is recruited to the Paf1 complex and FKS2 is 
transcribed. An initial investigation showed that in the absence of PAF1 PRS1 
transcription was reduced by approximately 50% (Chang et al., 1999). It is therefore 
possible to speculate that in the absence of PAF1 FKS2 transcription would be 
impaired as would PRS1 transcription, thus creating a scenario of compromised CWI 
which is consistent with the phenotypes associated with perturbation of the Prs 
complexes. Furthermore, disruption of Paf1 has a negative impact on the induction 
of galactose-regulated genes (Shi et al., 1996). Deletion of either PRS1 or PRS3 
abolishes growth on 2% galactose as the sole carbon source (Figure 3.2) whereas 
deletion of PRS2, PRS4 or PRS5 had no effect, further evidence that the two sub-
complexes of Prs contribute differentially to certain aspects of yeast metabolism.   
 
(FKS2, CHA1, YLR042c, YKR013w, etc.)  Cell wall biogenesis genes   
(MLP1, etc.) 
Figure 4.1: Model for activation of transcription by CWI signalling. 
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4.1 Interdependence of Prs1 and Prs3 
Further insight into the interaction between the five Prs polypeptides has been 
gained by examining yeast strains which contain an integrated version of GFP-PRS1 
at the cognate locus. The results corroborate the genetic evidence for the existence 
of the Prs1/Prs3 complex since in the strain lacking PRS3 the GFP-Prs1 signal is 
lost (Figure 3.1). Restoration of the GFP-Prs1 signal was achieved by introducing a 
plasmid-borne version of Prs3 into the strain. Admittedly, the strength of the GFP-
Prs1 signal in the presence of a plasmid-borne copy of Prs3 is less than that of the 
WT (Figure 3.1, lanes (3), (8) and (9)). A possible explanation for this is that Prs3 
expressed from the plasmid pGAD-Prs3 is under the control of the ADH1 promoter 
which in the pGAD background has a constitutive, but low, expression (Bartel et al., 
1993). Interestingly, the presence of the GAL4 activation domain located between 
the ADH1 promoter and the PRS3 ORF does not interfere with the ability of Prs3 to 
stabilize Prs1. The Western blotting experiment also provides a possible explanation 
for the synthetic lethality caused by simultaneous deletion of PRS3 and PRS5 since 
in the absence of PRS3, Prs1 is unstable; therefore, such a strain is effectively prs1∆ 
prs3∆prs5∆.   
 
4.2  Interaction of Prs1 with the CWI pathway 
To verify the Y2H interaction of Prs1 with Slt2, as described in Wang et al. (2004), 
co-immunoprecipitation was performed using crude extracts of a yeast strain which 
contains an N-terminal GFP-tagged version of Prs1 at the PRS1 locus (Schneiter et 
al., 2000) and episomal, plasmid-borne copies of C-terminally FLAG-tagged WT Slt2 
and two mutated constructs thereof. One mutated plasmid was altered at the aa 
residues T190 and Y192 of Mkp1/Slt2. T190 and Y192 were converted to alanine (A) 
and phenylalanine (F), respectively and resulted in the loss of the two 
phosphorylation sites within the activation loop of Slt2 that are phosphorylated by 
Mkk1/2 (Figure 1.2) following activation of the CWI pathway. The other mutation in 
Slt2 converted lysine (K) at aa residue 54 to arginine (R), thereby blocking the kinase 
activity of Slt2 and preventing the activation of the transcription factor Rlm1 (Kim et 
al., 2007, Kim et al., 2008). The co-immunoprecipitation revealed that both the WT 
and the kinase-negative species of Slt2 interacted with Prs1; however, the non-
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phosphorylatable version of Slt2 did not. Furthermore, the faint GFP signal observed 
following interaction of WT Slt2 was not visible with either of the two mutant forms at 
30°C (Figure 3.4, lanes (3), (9) and (15)). Nevertheless, both WT Slt2 and the kinase 
inactive mutant slt2(K54R) interacted with Prs1 following the mild heat shock 
induced by shifting the incubation temperature from 30oC to 37oC (lanes (4) and 
(16)).  
Confirmation of the results of the co-immunoprecipitation was obtained by using a 
plasmid-borne, galactose-inducible C-terminally His-tagged version of Prs1 instead 
of the N-terminally GFP-labelled Prs1 chromosomally integrated at the PRS1 locus 
in combination with the FLAG-tagged WT and mutated versions of Slt2. The strain 
YN96-65 from which the entire coding region of PRS1 has been deleted, was the 
host strain for the plasmids (Figure 3.5). In the absence of galactose there was no 
interaction with any of the three Slt2 species tested (lanes (1), (4) and (7)). However, 
following growth in galactose His-tagged Prs1 interacted with both the WT and the 
kinase-inactive species of Slt2 and the signal strength increased in response to mild 
heat shock (lanes (2), (3), (8) and (9)). Galactose induction of Prs1 produced no 
signal at either 30oC or 37oC in the presence of the non-phosphorylatable version of 
Slt2 (lanes (5) and (6)).  
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Figure 4.2: Interaction of Prs1 with Mpk1/Slt2   
This figure illustrates the interaction of the Prs1/Prs3 subcomplex with Mpk1/Slt2 as demonstrated by 
Y2H (Wang et al., 2004) and co-immunoprecipitation. The dashed line (          ) linking Prs5 to Fks2 is 
suggested by the results obtained when the mutations S364A, S367A and S369A in Prs5 were tested for 
their influence on the expression of Fks2 (cf. 3.5.4). For further details of nomenclature, see legend of 
Figures 1.3 (modified after Levin, 2011).  
  
Taking the results of the two independent co-immunoprecipitation approaches and 
previous Y2H data (Wang et al., 2004) into consideration, there is now sufficient 
evidence to state that Prs1 and Slt2 interact with each other, most likely via NHR1-1 
of Prs1, when Slt2 is phosphorylated in its activation loop by MKK1/2 at T190 and 
Y192 with the signal increasing in strength following a mild heat shock. Therefore, 
Slt2 must be phosphorylated, i.e. the CWI pathway must be activated at least to this 
point, in order to associate with Prs1. This result is reminiscent of the finding by Kim 
et al. (2008) that the catalytic activity of Slt2 is not necessary for the association of 
Slt2 and Swi4; the latter is a component of the SBF dimeric complex (Swi4/Swi6) 
which in addition to being necessary for regulation of G1-specific transcription, 
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synthesis and repair of DNA (Harrington and Andrews, 1996), is also an endpoint of 
the CWI  pathway (Kim et al., 2008, Truman et al., 2009).  
A co-immunoprecipitation experiment in which the NHR1-1 has been deleted from 
the labelled version of Prs1 would be the final proof that the interaction between Prs1 
and Slt2 is dependent on the presence of NHR1-1. One would predict that there 
would be no interaction with any version, including the WT, of Slt2. Taking into 
account the data reported in section 3.1 and in (Ugbogu et al., 2013) it is highly likely 
it is the Prs1/Prs3 subcomplex which is associated with Mpk1/Slt2 since in the 
absence of PRS3 Prs1 appears to be unstable (Figure 3.1), an example of “guilt-by-
association” (Oliver, 2000) 
 
4.3  Isolation of the Prs5 polypeptide and associated proteins 
The data acquired and discussed so far, are compatible with Prs5 contributing to the 
maintenance of CWI. Exploitation of the tagged version of Prs5 expressed in either a 
WT background YN11-01 (prs5∆) or in the strain YN97-91 which is devoid of the 
Prs2/Prs4/Prs5 complex could be expected to throw some light on interacting 
partners of Prs5. It has been previously shown by Y2H that the yeast homologue of 
GSK3, Rim11, interacts with Prs3 and Prs5 (Vavassori, 2005, Wang, 2005, 
Kleineidam et al., 2009). Affinity purification of the His-tagged Prs5 followed by 
separation on SDS-PAGE revealed that elution with increasing concentration of 
imidazole gave rise to distinct protein bands which did not cross-react with the 
antibody against the His-tag. The band corresponding to the His-tagged Prs5 (Figure 
3.25, lane (6)) as well as the two non-crossreacting bands highlighted in lanes (4) 
and (5) were subjected to MALDI-TOF analysis (Domon and Aebersold, 2006, 
Bensimon et al., 2012). Using correlative yeast database searching seven peptides 
matched with Prs5 (S288c) and covered 36% of the 496 aa residues of this 
polypeptide. In agreement with the specificity of trypsin which cleaves specifically at 
the C-terminal side of the basic aa residues lysine and arginine (R/K) when they are 
not followed by proline (P) each of the seven peptides had either an arginine (R) or 
lysine (K) residue at its C-terminus with the aa residue immediately N-terminal to the 
first aa residue of the peptide was also either arginine or lysine. The longest peptide 
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identified extended from position 117-145 of Prs5 
(ENYTFESHPGTPVSSSLMTQRPGAESSLK; gi: 6324511) and coincides with the N-
terminal region of the NHR5-1 of Prs5 (Figure 1.4). A second peptide from position 
273-291 (IPDYQDAVIVSPDAGGAKR) matched a region of ribose-phosphate pyro-
phosphokinase from Wickerhamomyces ciferrii (GenBank: CCH46852.1, gi: 
406601506). One other match corresponded to a synthetic histidine-tagged 
glucoamylase construct (gi: 46398247) and the remaining four matches were with 
unknown proteins of fungal origin (Mascot database). The sample was also treated 
with alkaline phosphatase but no coverage of the Prs5 peptide reported to be 
phosphorylated was obtained, in agreement with the strain having been grown at 
30oC (Dr Catherine Botting, personal communication). According to MS/MS analysis 
the 42 KDa non-crossreacting band corresponded to Tef2 of S. cerevisiae (S288c) 
and the remaining 44 peptides recognized the translation elongation factor 1α from a 
variety of fungi (Mascot database).  
The material in the three excised bands (Figure 3.25, lanes (4), (5) and (6)) was 
subjected to electrospray ionization (ESI) which is suited to the analysis of complex 
peptide mixtures (Gygi and Aebersold, 2000). As was to be expected the highest 
number of matches, 119, was achieved for Prs5 from S. cerevisiae (S288c) with 55% 
coverage of the polypeptide. The MS/MS profile for Prs5 peptide (LIISNTVPQDR) 
extending from position 446-456 is shown in Figure 3.26. The additional 35 peptides 
did not match any other Prs polypeptides from S. cerevisiae. ESI of the 42 KDa band 
identified again Tef2 from S. cerevisiae (S288c) and other translational elongation 
factors of fungal origin. The 36 KDa band was analyzed by ESI and consisted mostly 
of peptide mixtures falling in the category of GAPDH proteins, e.g. Tdh1, Tdh2 and 
Tdh3 from S. cerevisiae (S288c) which are involved in the synthesis of 1,3-
bisphosphoglycerate found in the cytoplasm and the yeast cell wall 
(http://www.yeastgenome.org). 
An isolation of the His-tagged Prs5 polypeptide from the same two strains was 
repeated using His SpinTrapTM technology. The material eluted with 200 mM 
imidazole was separated by SDS-PAGE and a section of the gel-containing proteins 
with a MW in the range of 30-100 KDa was excised for each strain (data not shown). 
The material from the gel was divided into two aliquots for each strain, an intensely 
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stained band in the middle of the chunk. 29 proteins could be identified in the intense 
band of YN11-01 and included Prs3 and Prs5. The corresponding intense band from 
YN97-91 also identified 29 proteins, inter alia only Prs5 (Mascot database). 
Following ESI-QUAD-TOF the peptides obtained from the YN11-01 chunk could be 
matched to 488 proteins in the entire NCBI protein database 
(http://www.ncbi.nlm.nih.gov/pubmed) including Prs1, Prs3 and Prs5 from S. 
cerevisiae. Interestingly, the identified Prs1 peptide 
(229QGDHPNEEENIILSNGIQTAR249, gi: 6322667) is located in the NHR1-1 region of 
the Prs1 polypeptide. A further Prs1 peptide extending from 307-317 spanned the C-
terminal junction of NHR1-1 (Figure 3.27). This is further evidence that NHR1-1 is an 
integral part of the Prs1 polypeptide which links the Prs1/Prs3 complex to Mkp1/Slt2 
of the CWI pathway. 588 hits were found for the YN97-91 chunk, two of which 
corresponded to Prs3 and Prs5. Upon closer inspection of the data it was found that 
there were 11 proteins, including Prs3 and Prs5, from S. cerevisiae, common to both 
strains. Other proteins co-migrating with Prs5 are stress response proteins (Hog1, 
Bmh1), morphogenesis and glucose sensing regulators, transcription, protein 
synthesis and heat shock proteins (Yck2, Vma2, YJL177w, Hsp26, Zuo1) are 
included in Table 3.2. However, further investigation is required since there is a 
possibility that weak or transient protein interactions may not be detected. One 
approach would be to use Blue Native-PAGE or size exclusion chromatography, 
both of which separate components of protein complexes according to size. It is 
possible that as a result of the interaction between Prs1 and a component of the CWI 
pathway that Prs1 or the Prs1/Prs3 complex shuttles between the cytoplasm and the 
nucleus to accomplish the activation of the genes whose products are involved in the 
re-modelling of the cell wall. One approach would be to create GFP-tagged versions 
of Prs1 and Prs3 in centromeric vectors in order to detect any change in the location 
of the tagged proteins by confocal microscopy when the cells are exposed to 
conditions in which the CWI pathway is switched on. 
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Summary and perspective 
The results of this study presented here provide further evidence for dual 
functionality of the two Prs complexes Prs1/Prs3 and Prs2/Prs4/Prs5. The reason for 
the dual functionality may be related to the presence of the non-homologous regions 
(NHRs) in Prs1 and Prs5. Interestingly, NHR1-1 and NHR5-2, albeit to a lesser 
extent, both contribute to the maintenance of CWI. Co-immunoprecipitation has 
confirmed the interaction of Prs1 with activated, but catalytically inactive, Mpk1/Slt2, 
although the site of interaction has not been localized to the NHR1-1 as shown by 
Y2H analysis. The three neighbouring phosphosites in NHR5-2 have also been 
shown to play a role in the expression of Fks2, the alternative subunit of 1,3-β-GS, 
which is predominantly expressed under stress conditions and is an endpoint of the 
CWI pathway. On account of the existence of the NHRs one can describe Prs1 and 
Prs5 as moonlighting proteins (Jeffery, 1999). When complexed in the minimal 
functional units – Prs1/Prs3, Prs2/Prs5, Prs4/Prs5 – or in the two interacting sub-
complexes of Prs1/Prs3 and Prs2/Prs4/Prs5 they ensure that the essential 
metabolite, PRPP, required for metabolism is linked to the signalling pathway 
responsible for maintaining CWI. Data available in the PhosphoPep database 
(Bodenmiller et al., 2008) is consistent with the first aa of NHR1-1, S199 being 
phosphorylated by Torc1 and Mkk1, both of which are components of the CWI 
pathway. Knockouts of either of these two kinases resulted in a 1.9 and 1.6-fold 
increase, respectively, in the expression of PRS1. It is intriguing to speculate that 
these two kinases may influence Prs1 expression in concert with the activation of the 
CWI pathway.  
A potential kinase candidate for the three phosphosites in Prs5 NHR5-2 is Rim11 
(Bianchi et al., 1993, Hirata et al., 2003, Griffioen et al., 2003, Yabuki et al., 2014) 
which has been shown in a high-throughput assay to interact with Prs2, Prs3 and 
Prs5 (Ho et al., 2002) and confirmed by us in Y2H analysis (Kleineidam et al., 2009). 
Preliminary Y2H analysis indicates that mutation of the three phosphosites interferes 
with the interaction of Prs5/Prs4 and Prs5/Rim11 (Young, 2012) (E. Young, 
unpublished data).  
One aspect of PRPP metabolism, not addressed in this study, is the impact of 
mutating PRS genes on nucleotide pools. An interrogation of SGD has shown that 
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Ixr1 which regulates the expression of the ribonucleotide reductase, Rnr1 is involved 
in the maintenance of dNTP pools (Yao et al., 2003, An et al., 2006) and also 
regulates Prs1 and Prs3 in opposite ways. Interestingly Ixr1 is implicated in the 
regulation of Prs1, Prs3, Rim11, and Rlm1 (Tsaponina et al., 2011).  
The synthetic lethality of a prs1∆prs5∆ strain can be rescued by a WT copy of PRS1 
as well as by versions of PRS1 mutated in the Mg2+/ATP and the PRPP-binding sites 
or in conserved residues corresponding to missense mutations associated with 
human neuropathies. However, the presence of NHR1-1 is essential for the rescue 
of the synthetic lethality, as was also demonstrated by the inability of hPRPS1 which 
does not contain an equivalent of NHR1-1, to rescue synthetic lethality (Ugbogu et 
al., 2013).  
The results obtained will also prove useful in the international project aimed at 
constructing a ‘designer’ yeast containing synthetic chromosomes (Annaluru et al., 
2014, Pennisi, 2014). It would appear that at the very least S. cerevisiae has a 
requirement for the product of the PRS1 gene on account of its role in the 
maintenance of CWI and for the PRS3 gene since, when this is absent, Prs1 is 
unstable.  
Although the investigations have been performed in yeast the reaction carried out by 
Prs is found in all organisms with the exception of parasites which rely on the host’s 
metabolism. . This would offer the opportunity of exploiting Prs as a drug target. 
Information gained from the yeast PRS genes could identify region(s) in the unique 
bacterial PRS gene which could be targeted for drug therapy. A further example 
relevant to the broader biomedical application of this work is provided by the 
considerable sequence similarity of the S. cerevisiae and Candida albicans Prs 
polypeptides (CGD, http://www.candidagenome.org/). Such information may be 
beneficial in identifying potential drug targets against candidiasis (Maubon et al., 
2014), the most common deep-seated human fungal infection that endanger the life 
of the patient. 
In humans increased Prs activity is associated with gouty arthritis whereas reduced 
Prs activity is associated with human neuropathies. In the long time it might be 
possible to find a way of interacting with the hPRPS complex, such that Prs activity 
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could be modulated to reduce the superactivity associated with gouty arthritis. 
Another, more speculative approach would to investigate the PRPS-associated 
polypeptides (PAPs) which are thought to exert a regulatory function on Prs  
(Tatibana et al., 1995). Such an approach might, in the long term, lead to a means of 
regulating Prs activity in humans to counteract the reduce activity associated with 
human neuropathies.  
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